Skip to main content

Full text of "The chemist and druggist [electronic resource]"

See other formats


HEMIST& 
RUM 



HE NEWSWEEKLY 



PHARMACY 




I I I I I I I I I I I I I I I I I I 

The UK's best-selling toothpaste* 
...now with stripes! 

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 



i i i i i 



x 

% 



X 




20 July 1996 



I i I i I 



3,000 pharmacies 
may go if RPM lost 

Malone go-ahead for 
season ticket sales 

Sex attack pharmacist 
struck off Register 

Update: performance- 
enhancing drugs in sport 

Keeping a 
watching 
brief on 

eye care SK> 

Pharmacists' biggest 
fears are revealed 

Sunderland TV star 
Ortis looks for 'lurve' 



Online at http://www.dotpharmacy.com/ 




- 



When your customers 




Household chemicals 



Detergent hands 



are itching to scratch, 



d I X 



I v 



/ V 



Plant allergy 



Insect bites 



you've no better way 



( ) 



Eczema 



Nickel allergy 

to relieve them. 



hydrocortisone 
cream 



WO -[ 5 HIVING ^ 



HC45 Hydrocortisone Cream quickly soothes itchy, inflamed, 
irritated skin to provide the fast relief your customers need. In fact 
there's no better recommendation you can make. 

Trusted relief from everyday skin irritations 



PRODUCT INFORMATION: Hc45 HYDROCORTISONE CREAM: Smooth white cream 
containing HYDROCORTISONE ACETATE BP 1% w/w. Uses: For the relief of mild to moderate 
eczema, irritant and allergic contact dermatitis and insect bite reactions. Dosage & Administration: 
Apply sparingly to a small area, once or twice a day, for a maximum of seven days. Contra-indi cations, 
Warnings etc: Hc45 should not be used on the eyes or face, the ano-gemtal area or on broken or 



infected skin, including lmpeogo, cold sores, acne or athletes foot. The product should not be used 
in pregnancy or in children under 10 years without medical advice. Packaging Quantity: Tube 
containing 15g. RSP: £2.65. Legal Category: P. Product Licence Number: PL 0327/0039. 
Product Licence Holder: Crookes Healthcare Ltd., Nottingham ^^^k CROOKES 
NG2 3AA Date of Preparation: June 1996. ^^^F HEALTHCARE 



c 



COMMENT 



ongratulations to the Community Pharmacy 
Action Group lor its hard-hitting, albeit bleak 
reading, report on the impact of abolishing 
Resale Price Maintenance. 
Although it confirms the worst fears of 
pharmacists (see Business News, p96), it states 
the pharmacy case effectively, while stressing the 
pharmacy's importance in the community. 

Of course, there may be those, both within and 
without the profession, who see mass pharmacy 
closure as for the common good. And it is also 
disappointing to see other health professionals 
backing Asda's stance, but it's hard to see how 
there can be any long-term gain. The ultimate effect 
of job losses, increased GP burden and dissatisfied 
patients will be a hard one to bear for a 
Government which introduced a Patient's Charter 
and for GPs already burdened by overwor k. 

It is patients to whom the Office of Fair Trading 
must look when considering RPM's fate, so it is 
good news that the Patients' Association has also 
come out battling in the pharmacy comer (p78). 

Guy Howland, the organisation's chief executive, is 
a fervent pharmacy supporter. He believes the 
profession's accessibility is key to its patient 
popularity and stresses that that must be maintained. 
He points out that the supermarkets who are trying 
to change pharmacy aim to "make a fast buck, rather 
than having anything to do with patients". 

In contrast, he feels the local pharmacy could be 
expanded to offer more services for patients to 
supplement those on offer from the surgery. 

His response is one of the positive spin-offs from 
the whole RPM debate. Support such as this, 
backed by the Deloitte & Touche (TAG report, will 
have a long shelf-life and may be used in the future 
to help pharmacy reach its potential - hopefully 
with the RPM debate settled in the profession's 
favour. 



CHEMIST& 
DRUGGIST 



Editor Patrick < rrice, 
MRPharmS 

Assistant Editor Maria 
Murray, MRPharmS 
News Editor Marianne Mac Donald, MRPharmS 
Technical Editor Fawz Faihan, MRPharmS 
Beauty Editor Joanne Webb 
Business Editor Guy L'Aimable, BA 
Contributing Editor A< Incline de Mont, MRPharmS 
Reporter ( lharles < lladwin MRPharmS 

Art Editor Tony Lamb 

Production Editor Vanessa Townsend, BA 

Price List Colin Simpson (Controller) 
I tarren Lai Kin, Maria Locke 

Advertisement Manager .lull. in de lirnxelles 
Assistant Advertisement Manager Doug Mytton 
Display Advertisement Executives 

Martin < lalder-Smith, Nick Fishet 

Production Jenny I latl 
Publisher Ron Salmon, FRPharmS 
Publishing Director Roger Murphy 
<0 Miller Freeman pic. [996 



Chemist & Diuyiiisl mcorporatinij Retail 
Ohwiir.l ^ I'Imiiii.ii v Hpij.ili: 

Published Saturdays hy 

Mi Her Freeman Professional I td 

Sovereign Way, Timlnirlqe. Kent TN9 1RW 

telephone 01732 364422 

Telex 95132 Milt RE G 

Fax: 01732 361534 

E-Mail: tlieiiidrii() ,( ?ilnt|ih.imiacy com 
Internet site 

Imp //www ilnlpli.imi.il y i urn/ 

Subscriptions Home £115 per annum 
Overseas & Eire t'ltj 1 . pel annum 
including postage 
£2 40 pei copy (postage extial 

Circulation and subscription Royal 
Sovereign House, Beresford Street 
London SI I86BQ hi 0181 855 //// 

Refunds on cancelled subscriptions will 
only In' provided at the publisher's 
discretion, unless specifically 
guaranteed within the terms ot 
subscription offer 

The editorial photos used are courtesy 
of the suppliers whose products they 
feature. 

\fl Miller Freeman 



ABC 



BUSINESS PRESS 



CHEM& 
DRUGGIST 



VOLUME 247 No 6044 136th YEAR OF PUBLICATION ISSN 0009-3033 



76 



Report commissioned by the Community Pharmacy Action 
Group spells out the clangers if Resale Price Maintenance is lost 



Oxygen services to be devolved to local level 77 

I )e] lartment of Health to devolve oxygen services by October 1 

Pre-papent certificates to be sold through pharmacies 77 

Regulations to be amended to allow sale directly to patients 



From Practice to People 84 

Show how yon work in practice and win a prize! 




Update: the dope hope in sport 

Drugs in sport, pharmacy needle exchange 
schemes, plus Research Digest 



Hill 



care 90 

Trends and changes in the eye care market 




Counterpart assistant training 94 

There is si ill time to register staff! 



Nurse prescribing regarded as an opportunity by many 96 

( Haxo survey reveals threats and opportunities for pharmacists 

Co-op Health Care continues to expand 96 

Five pharmacies acquired in North Midlands and North West 



Dental relief aid deliver}' to Bihac in Bosnia 

A pharmacist helps to deliver essential dental supplies 



102 



REGULARS 



News 


76 


Cambridge Counterpart 


94 


Topical Reflections 


73 


Business News 


96 


Prescription Specialities 


80 


Classified Advertisements 


97 


Counterpoints 


82 


Business Link 


98 


Practice to People 


84 


About People 


102 



CHEMIST k DRI GGIST 20 JULY 1996 



75 



NEWS 



000 pharmacies could go if RPM lost 



Over 3,000 community pharma- 
cies could face closure if Resale 
Price Maintenance is lost, reveals 
a report commissioned by the 
Community Pharmacy Action 
( rroup. 

"Our concern," says CPAG 
spokesperson and director of the 
National Pharmaceutical Associ- 
ation Tim Astill, "is that the 
removal of RPM would force the 
closure of many small pharma- 
cies and reduce the services pro- 
vided by others, resulting in a 
threat to public healthcare." 

The 'In defence of community 
pharmacy' study by management 
consultant Deloitte & Touche 
shows that the public would 
have access to fewer pharmacies 
and would be forced to travel fur- 
ther to get pharmaceutical 
advice, with the 1 proportions of 
vulnerable groups, such as the 
elderly and those with young 
families, higher in the areas most 
at risk. There would also be a 
reduced range of over the 
counter medicines available and 
job losses would be incurred. 

The < >ftk e of F ur Tr riding last 



investigated RPM in 1970 and is 
to decide by the autumn if there 
is any material change thai 
would allow its demise. The 
report divulges that there is 
change, but it strengthens the 
case for RPM retention, as phar- 
macists are now more reliant on 
branded medicines. 

In 11)70, the average small 
pharmacy derived 7 per cent of 
turnover from medicine sales 
and 10 per cent, from NHS dis- 
pensing, with the margins on the 
latter at around 26 per cent. Now 
NHS dispensing accounts for 70 
per cent of turnover, with mar- 
gins down to 16 per cent, while 
OTCs are responsible for 15-16 
per cent of turnover, around 45 
per cent of the profit. 

The upshot of losing RPM 
would be a saving of S180 mil- 
lion, plus another in 00, 000 saved 
in policing. 

"Without RPM," says Mr Astill, 
"there might be a short-term 
gain, but there will certainly be a 
long-term loss." And 91 per cent 
of pharmacists surveyed by 
<ilaxo Wellcome believe their 



Numark is 
tackling the 
supermarkets 
head-on with a 
pharmacy advice 
campaign. Terry 
Morris, Numark's 
managing 
director, sees the 
campaign as a 
complement to the 
Resale Price 
Maintenance 
defence: "Numark 
totally supports 

the retention of RPM and what we want from this campaign is for the 
consumer to ask the question: when did a supermarket shelf last 
advise me not to buy something?" Numark's 900 shareholder 
pharmacies will highlight the advisory role of trained pharmacy staff 
and compare that with what's on offer in an ordinary supermarket via 
posters and shelf cards, which ask a series of advice-related 
questions and issues the challenge: Try asking your supermarket shelf 
these questions' 




business viability will be threat- 
ened (Business News, p96). 

Supermarket chain Asda, at 
the forefront of the fight to abol- 
ish RPM, comments: "We are 
well aware of the services that 
community pharmacies deliver 



The impact on healthcare of abolishing Resale Price Maintenance 



• Up to 3,055 pharmacies 
would be at risk of closure: one- 
quarter of Britain's total. 

• Up to 8.2 million people 
whose pharmacy is at risk of clo- 
sure could be affected. 

• Additional travel costs of 
between S4.4 million and SI 5.9m 
would be incurred by people 
affected by the closure of their 
local pharmacy. 

• If a tenth of those who treat 



themselves with pharmacy- 
bought medicines were to visit a 
GP instead, the annual cost to 
the NHS could be more than S4.7 
billion. 

# The range of non-prescrip- 
tion medicines available would 
be cut: the average pharmacy 
carries 700 OTC lines, while 
supermarkets cany 70. 

• Between 800 and 3,000 jobs 
could be lost if pharmacies close, 



not including any pharmacists. 

• The benefits of RPM would 
be a saving of SI 80m if prices 
were cut across the board (6p 
per person per week ), but super- 
markets are more likely to offer 
seasonal reductions on adver- 
tised products rather than 
wholesale discounting. 

• The cost of administering 
RPM, around S100,000 annually, 
would also be saved. 



to the local community, but we 
do not believe that RPM supports 
local pharmacies." 

Asda says that GPs and nurses 
back its stance on RPM. In an 
Asda mailing to 30,000 GPs, some 
7,500 replies agreed that RPM 
results in artificially high prices 
for "common healthcare prod- 
ucts". Only 40 replies disagreed. 

But backing for RPM comes 
from an even more powerful 
source, the Patients' Associa- 
tion. "With RPM loss there will be 
a trade-off," says chief executive 
Guy Howland. "Lowering prices 
will undoubtedly cause some 
exist ing pharmacies to close and 
reduce choice. The public like 
the access they currently get 
from pharmacies and we need to 
keep that available." 

The OFT has been sent a copy 
of the Deloitte & Touche report. 



Pharmacists to be more clinical with methadone? 



Pharmacy Group 

MPs disappear from Westminster 
for their three-month summer 
break on July 20, with no sign of a 
long-awaited Pharmacy Group 
being established to promote the 
interests of the sector. 

Tory MP Sir Malcolm Thornton 
and Labour's Alan Keen said last 
year that they planned to set up a 
group to lobby on behalf of phar- 
macies and vowed to launch the 
body early this year. 

But Sir Malcolm admits he has 
dropped out because of a lack of 
time. "Unfortunately, I ran up 
against the buffers," he says. 

Mr Keen's office says the group 
has yet to be set up, but insists 
that the MP for Feltham still 
intends it to go ahead. 



Pharmacists' potential to adopt a 
more clinical role in managing 
methadone patients is to be 
investigated by South Humber- 
side's pharmacist-run Freelance 
Needle Exchange. 

Community pharmacist Dr 
Rod Tucker, director of the Free- 
lance Group and devisor of the 
study, says: "The overall objec- 
tive ( if the project is to determine 
whether or not pharmacists can 
play a greater role in the clinical 
management of opiate-depen- 
dent individuals." 

South I lumber Health Author- 
ity is paying SI per addict per day 
for pharmacists to supervise the 
methadone consumption of 30 
patients over 13 weeks, plus an 
additional S750 for evaluation. A 
clinical audit, sheet will be main- 
tained and clients will be 



assessed using an opiate with- 
drawal scale to titrate the 
methadone dose. An initial three- 
day assessment by the referral 
agency scores various signs and 
symptoms, such as sweating, agi- 
tation and mydriasis, to establish 
the degree of withdrawal. The 
dose is titrated upwards until 
symptoms are under control. 

Thereafter, the pharmacist con- 
tinues daily monitoring of the 
patient using the same scale. A 
change in the patient's drug-tak- 
ing habit, such as taking addi- 
tional opiates, can also be indi- 
cated by changes in routine or 
behaviour. 

Every fortnight during the pro- 
ject, the withdrawal scales are 
scored and given to the prescrib- 
ing agency responsible for the 
overall management of the client. 



From Practice to People - 
deadline imminent 

You've got less than two weeks 
to enter the Glaxo Well- 
come/C&D community phar- 
macy award, From Practice to 
People (see page 84). 

The award will be granted to 
three community pharmacists 
who show how they are forging 
links with other health profes- 
sionals to benefit patients, 
other primary care workers and 
their business. Closing date for 
entries is July 31, 1996, and win- 
ning entries will be announced 
on November 9. 

Winners will be offered the 
chance to attend one of the 
major 1997 conferences or 
choose from a range of manage- 
ment courses. 



76 



CHEMIST & DRUGGIST 20 JULY 1996 



NEWS 



Oxygen to be devolved on October 1 



The I 'epartmenl oi Health is to 
devolve oxygen services i<> local 
level by < ictobei 1 

The Pharmaceutical Services 
Negotiating Committee, winch 
has opposed the move, will write 
to local pharmaceutical commit- 
tees with a model for local nego- 
tiations as soon as it receives 
mure detailed guidelines. 

The NHS Executive expects 
agreements wit h heall h auttv »ri- 
ties in I"' made by January 1, 
l!i!)7 ( 'ontractors should carry 
on as before unlil they receive 
further advice from then LP( 's. 
The number of oxygen head sets 
is to lir reduced, but contractors 

who have to give up head sels 

will be paid compensation. 
PSN< ' warns dial monej is only 
available f< a this financial year. 
Remuneration The hull and 
PSNC are poised on the brink of 
a remuneration settlement foi 
l!)!)ii/!i7. PSNC has been 
pr< mused an i iffei I iefi »r< 1 the end 
ol the month, aftei ii met with 
health minister Gerald Malone. 
This followed PSNC's rejection 



oi the Moll's last offei of 3 per 
cent in May (C&D May 25, p712). 

PSNC chairman Wally Dove 
says thai the offei w ill m it be put 
to contractors. Providing an 
agreement is reached then 
PSNC will discuss the distribu- 
tion of the global sum at its Sep- 
tember meeting and the new 
si ruct ure sin mill be in ] ilace by 
t ictobei 1 

Director The first advertise- 
ment for the new position of 

duei lor w ill be placed Ihls week 

iii the PSNC News and pharma- 
ceutical piess 

MPs The PSNC wants to thank 
tin isc pharmacists who wr< ite to 
their MPs to raise awareness of 
pharmacy remuneration It also 
wants io encourage LP( 's to con- 
tinue inviting MPs to \ isii phar- 
macies, so thai they gel a bettei 
understanding ol community 

phai ma< V issues 
Control of Entry Most of the 
comments made by PSNC over 
the draft guide concei ning ( 'on- 
trol ol Entry regulations have 
been acce] ited I iy the DoH and 



will be inc< »rj » >rate< I into the sec- 
ond draft. 

Taxation advice Advice will be 
senl to LP< 's setting oul the lax 
implications for allow ances paid 
foi members attending LPC 
meetings. 

Primary care The I lull has indi- 
i ated that the NHS Executive 
would welcome further position 
papeis from PSN( ■ on the health 
minister's paper 'Primary care: 
the future'. PSNC will place 
emphasis on the need for non- 
global sum money to be made 
available for local initiatives. 
Pilot trials PSNC has been in 
discussion with the DoH over 
pilot trials in 1996/97. Il is stress- 
in;; thai pharmacists should 
receive then share of any money 
saved m icpeai dispensing 
pilots. 

GP co-operatives PSN( is con 
cerned that there has been no 
national approach by local med- 
ical councils to the pharmacy 
pi c pfessii m ovei the setting up i >l 
GP co-operatives to provide 
emergency oul of hours medical 



services. PSNC secretary Steph- 
en Axon is against health author- 
ities extending existing phar- 
macy rota hours to beyond those 
of surgeries 

NAIIAT PSNC wants to create a 
dialogue with the National Asso- 
ciation of Health Authorities and 
Trusts over developing pharma- 
ceutical services. It is hoped that 
money other than the global sum 
will be made available fi ir such 
services. 

Conference The third confer- 
ence organised jointly with the 
Royal Pharmaceutical Society 
and the Pharmaceutical Advisers 

( JrOlip W ill be held al the Mello- 

pole Hotel, Birmingham, on 
Novembei 7. The theme will be 
'Pharmacists as partners in 
healthcare'. 

LPC Conference PSNC has 
received comments from 
LPCs about the March confer- 
ence. The Committee will be 
looking at making the working 
group sessions more interactive, 
ami will be targeting MPs more 
lor the dinner. 




New research suggests that hairy men are more intelligent. More details can be found on p80 

Sale of season tickets receives go-ahead 



Pharmacists are to be allowed to 
officially sell prescription pie 
payment certificates. The health 
minister, Gerald Malone, an- 
nounced in a written answer lasl 
week that the Gi ivei iinient "pro 
poses to amend cm rent regula- 
tions later this yeai to allow com- 
munity pharmacists who wish to 
do so lo sell prescription pie 
payment certificates directly to 
patients". 
Al present, patients must 



apply directly to then health 
authority, but m some areas 
pharmacists have been supply- 
ing certificates with the tacit 
approval of the 1 IA 

"We have been making repre 
sentations lor some time foi a 
change in the regulations," says 
Pharmaceutical Services Negoti- 
ating Committee assistant secre- 
tary Mike Kins*. "Now we will he 
discussing details with the Nils 
Execul ive." 



A Department of Health spokes- 
man says Ihe changes should be 
made bcli n e next April and discus- 
sions a i e in progress with relevant 
bodies. One of the DoH's main con- 
cerns is Ihe security ol the certifi- 
cates held in pharmacies 

The National Asthma Cam 
paign has been lobbying lor a 
greatei awareness of 'season 
tickets', which Mr Malone says 
will be further publicised after 
I he n 'gulat ions are changed. 



certification and reward 

Medicines counter assistants 
are m iw completing ( 'hem ist & 
Dnifjgist's ( 'am bridge < ounler- 
part course and certification is 
under way. 

The College of Pharmacy 
Practice hopes to have its cer- 
tificates of accreditation 
printed by Ihe end of July. < '&D 
will then begin a search of its 
computer records to find out 
which assistants have success- 
fully passed all modules in the 
previous lour weeks; their 
pharmacist will then get a letter 
lo sign and rel urn confirming 
joint c ompletion ol' all case 
studies and that each assis- 
tant's customer communica- 
tion skills are satisfactory. 
Within one month of receipt of 
that letter from ihe pharmacist 

the assistant should receive a 

CPP certificate of accredita- 
tion. 

Each month, ( \Ki> will give 
bottles ol' champagne lo a suc- 
cessfully-accredited assistant 
and their pharmacist - one PIN 
will be draw n from a batch ol' 
accreditees. 

Al Ihe end of this year, one 
accredited assistant will win a 
weekend holiday lor two by 
prize draw, courtesy ol' White- 
hall Laboratories, 
• Registration form and fur- 
ther information on page 9 1. 



CHEMIST H. DKI GGIST 20 JULY 1996 



n 



s 




Pharmac ists should be given an 
expanded role in the primary 
care arena, according to the 
Patients' Association. 

Guy Howland, PA chief execu- 
tive, says the Association is in the 
process of writing a paper on the 
future of pharmacy, which will 
place pharmacists at the fore- 
front of primary care. "Our whole 
thrust is that we want to see a 
role switch from dispensing to 



A veteran pharmacist who 
bought more than £11,000 of 
drugs from the hack of an un- 
licensed wholesaler's car was 
or dered to be struck off the Reg- 
ister this week. 

John Aloysius Judge, 56, super- 
intendent pharmacist at Snow- 
drop Pharmacy, Canterbury, 
admitted purchasing unlicensed 
drugs, but claimed he had been 
unaware that I hey were unli- 
censed at the time. 

His supplier - Pierre Schaffer 
of Palm Bay, Margate - has 
already been responsible for the 
striking off of 1 1 other pharma- 
cists, with four more yet to 
appear before the Statutory 
Committee ol Ihe Royal Pharma 
ceutical Society. 

Society inspectors visited Mr 
Judge's pharmacy in October, 
1993, where they discovered 22 



A pharmacist who terrorised a 
young woman by breaking into 
her flat and asking for sex was 
struck off the Register by a disci- 
plinary panel this week. 

Rajinder Singh Atwal, 25, who 
was studying at Manchester Infir- 
mary at the time, was jailed for 
four years by Manchester Crown 
Court in May last year, after 
being convicted of burglary with 
intent to commit rape. He gradu- 
ated from John Moore University 
in Liverpool just a year before 
forcing his way into the 25-year- 
old woman's flat and threatening 
to sin >ot her if she didn't have sex 
with him. 

The Statutory Committee of the 
Royal Pharmaceutical Society was 
told Mr Atwal had been out drink- 
ing on the night of the offence, cel- 
ebrating the successful presenta- 
tion of a paper on ast hma and a job 
offer with Lloyds Chemists. 



undertaking consultations, ad- 
vising, prescribing and supple- 
menting the work of the doctor 
and nurse," says Mr Howland. 

He believes that pharmacists' 
skills can be put to better use. "If 
we do not utilise the skills in pri- 
mary care more effectively, then 
primary care as we know it will 
not survive. Let's get pharmacists 
to solve the primary care crisis." 

He feels that there should be a 



consignments of products from 
Mr Schaffer, worth SI 1,301. 

Josselyn Hill, solicitor to the 
Society, told the hearing that Mr 
Judge, who had been practising 
for 32 years, bought medicine 
from the back of Mr Schaffer's 
car and received handwritten 
invoices, although not all of the 
products were unlicensed. 

Mr Judge of Petham, Canter- 
bury, who admitted misconduct, 
said he had trusted Mr Schaffer 
and assumed his supplies were 
"authentic". 

Mr Judge said he had been told 
by Mr Schaffer that he would be 
supplied at "much keener" prices 
because he had taken care of Mr 
Schaffer when he suffered a dia- 
betes attack in the pharmacy. 

In a letter to the Society, Mr 
Judge, who sold the pharmacy in 
February this year but continued 



Detective sergeant Steve Mc- 
Gahey told the hearing the victim 
had gone to bed at 1.45am on the 
night of June 24, 1994. At around 
3.30am, Mr Atwal approached 
the entrance to the block and 
began talking to two residents 
who believed he knew somebody 
and let him in. "He forced the 
front door of her flat and went to 
her bedroom. She awoke and 
saw him standing close to her 
bed." 

Mr McGahey said the victim - 
who did not know Mr Atwal - 
asked him how he got inside her 
home. He showed her a bunch of 
keys and claimed he had believed 
a girl called Leigh lived there. 

"He then asked her if she 
would consent to making love 
with him and said she would 
have no choice in the matter 
because he would shoot her. She 
was absolutely terrified and 



re-think on training so that all 
health professionals share a core 
base, and pharmacists will be 
allowed to develop their diagnos- 
tic and prescribing skills. 

The report is expected in Octo- 
ber, but the PA is keen to collate 
pharmacist evidence on how 
progress can be made. Informa- 
tion should be sent to: The 
Patients' Association, 8 Guilford 
Street, London WC1N IDT 



to work as a locum, said: "With 
the benefit of hindsight, I accept 
my actions were at best naive 
and at worst stupid." 

In mitigation, David Reissmer 
told the Committee that Mr 
Schaffer was a trickster who had 
possibly put on his "hypoglae- 
cemic attack" to gain Mr Judge's 
sympathy and confidence. 

"It was not more than ig- 
norance in that he did not know- 
some of the drugs were un- 
licensed, although he accepts 
today that he should have done." 

(fiving the Committee's deci- 
sion, chairman Gary Flather QC 
said Mr Judge is one of the 
longest-serving pharmacists to 
have been caught out in the 
'Schaffer affair'. He told Mr 
Judge that the Committee would 
not entertain any application for 
restoration for nine months. 



started shouting 'rape' loudly." 

Mr Atwal then panicked and 
ran from the flat. However, he 
was unable to find the way out 
and he smashed a window. 
Bleeding profusely, he then 
banged on another resident's 
door claiming he had been 
mugged. He was taken to hospi- 
tal but was later arrested after 
the woman called the police. 

Mr Atwal, who is now serving 
his prison sentence, broke down 
in tears as he told the Committee 
he could make no excuse for his 
behaviour. He said he committed 
the offence "in a drunken haze". 
Committee chairman Gary 
Flather QC said the Committee 
had no option but to strike him 
off because of the conviction but 
added that the Society would 
entertain an application for 
restoration in 1998 - he is due for 
release in Dec ember next year. 



WCPPE goes on-line 

The Welsh Centre for Post-gradu- 
ate Pharmaceutical Education 
can now be accessed on the 
Internet. 

Aimed mainly at pharmacists I 
living in Wales, the site offers an 
index of literature for community 
pharmacists, a calendar of Welsh I 
pharmacy events and articles 
published or presented by the 
WCPPE's staff. 

This will soon be expanded to 
offer a distance learning pack 
ordering system or allow reserva- 
tion at a WCPPE evening course, 
with plans to put computer- I 
assisted learning material onto H 
the Net . The WCPPE's home page 
address is http://www.cf.ac.uk/ 
uwcc/phrmy/WCPPE/pindex. 
html. Its e-mail address is at: I 
WelshCPPE@cardiff.ac.uk. 
• Boots has also set up an Inter- 
net site (Website address: www. I 
Boots.c-o.uk.) offering advice on 
common ailments, pharmacy ser- 
vices and a vitamin database. 

More Sun E45 
recalls for Crookes 

Hot on the heels of last month's 
recall of seven batches of Sun I 
E45 Sun Block Cream, Crookes 
Healthcare is now recalling all 
remaining stock of Sun E45 Fac- 
tors 8 and 15. 

Stock should be returned to 
wholesalers or Crookes' territory 
managers. Full refunds will be 
given, with replacement stock 
available from July 29. Pharma- 
cists with any queries should tele- I 
phone 0115 968 8711. 

MCA cuts waiting 
time for assessment 

The Medicines Control Agency is 
maintaining its status as the 
fastest authority in the world for I 
1 1 ii ■ assessment i 'I new di ngs 

The MCA's sixth annual report I 
and accounts for 1995/96 shows I 
that the Agency has cut the mean H 
assessment time to 51 days for 
applications containing new ac- 
tive substances. Application fees 
have also been reduced by 
4 per cent. 



Slimming pills stay 

The Department of Health has 
rejected calls for a ban on slim- 
ming pills, such as dexenflu- 
ramine, fenfluramine and maxin- 
dol, arguing that the drugs can be 
useful in the treatment of obe- 
sity. However, health minister 
Gerald Malone has asked for 
tighter prescribing guidelines. 



Schaffer affair rolls on and on 



Striking off follows sex attack 



m 



CHEMIST & DRUGGIST 20 JULY 1996 



Over 80 per cent of 
elderly on repeats 

( Iver so per cciii of eldei ly patients 
are on repeal prescriptions, bui a 
quarter are inconvenienced by hav- 
ing in make a return trip in the 
pharmacy because of 'owings'. 

According to a survey by Help 
the Aged, the mosl popular service 
Offered by pharmacies is home 
delivery, used by lo pei cenl of the 
over-70s. Around a third of those 
surveyed in England and Wales said 
they were nol completely satisfied 
with their current means of receiv- 
ing repeals 

"The efforl of visiting GPs and 
having to keep visiting pharma- 
cies adds up In a .ureal deal of 
time an inconvenience," says 
Help the Aged's head of public 
affairs, Mervyn Kohler. 

The report also reveals thai 

71 per cenl of people o\el 60 

suller from ai leasl one long- 
standing illness. half 1 1 (nil 
rheumatism oi arthritis, a third 
from hypertension, and respira- 
tory illness or heart disease 
afflicts one-quat ter. 

SHS hits the road 

If you feel ignorant about coeliac 
disease or have patients who 
would like lo know more, then 
Scientific Hospital Supplies has 
the answer. 

In a series of SHS autumn sem- 
inars, aimed specifically at phar- 
macists and their customers, a 
gastro-enterologist will reveal 
the latest advances in research, 

w hile a Iu\ ela home ec( inoiuisl 
will demonstrate gluten-free 
recipes 

The seminar dales are Septem 
ber 5 (Dundee), ( ictober 18 (Nor- 
wich) and Novembei 28 (South- 
aiuplon ) Kurt her inloi mat i< m is 
available from the Juvela adv ice 
line on 0151 228 1992. 

( loeliac disease affects one per- 
son m every 2,500 in the UK. 

CPPE workshop on 
patient counselling 

The ari of patient counselling 

collies under the microscope in 

the ('cnirc foi Pharmacy Post- 
graduate Education's autumn 

W ' irkshl )| i series 

The counselling skills series 
will run from September lo 
December, with the help of local 
( TITO i utors and presental i< >ns I >y 
qualified counsellors 

Topics lo be explored iik hide 
the need for counselling and the 
additional skills required, 

The ( !PPE's workshop pro 
gramme in spring will locus on 
medicines management, which 
will he selected on a local basis. 



A fair day's 
pay ,„ but 
only for some 

I make no apology for quoting 
from the front page of the 
Guardian (Thursday, July 11): 
"There can be very few people 
here or anywhere else who 
have sacrificed more in pay 
restraint than members of this 
House," Alf Morris, Labour. I 
beg to differ. In case Mr Morris 
is unaware of pharmacy's 
current problems, there is one 
profession which has not only 
sacrificed but has been 
sacrificed on the altar of 
Treasury frugality. 

Community pharmacy is 
rapidly approaching a crisis of 
recruitment that is purely a 
function of the dissatisfaction 
of pharmacists at the salaries 
currently being offered. Our 
pay is an insult to any 
profession and would be 
laughable if it was not so 
serious. Job seekers are 
voting with their feet and 
employers are now resorting 
to overseas recruitment in 
order to fill the gap left by our 
own graduates who are 
seeking employment 
elsewhere. 

I do not expect that the 
Department of Health will pay 
any more attention to the 
current situation than it has to 
reasoned argument in the 
past. However, before the 
service is starved of the vital 
new blood it needs to develop 
its own 'New Age', perhaps 
Mr Morris and his like-minded 
parliamentarians should be 
reminded of pharmacy's 
parallels. Having enjoyed the 
luxury of voting for their own 
fair pay rise, might they now 
pressurise the DoH into 
similarly granting community 
pharmacy's reasonable 
demands? 

Playing piggy 
in the middle 

The saga of melatonin has 
moved on since I last made 
light of a situation that could 
now find retailers as piggy in 
the middle of a serious 
confrontation between the 
Medicines Control Agency and 
healthfood manufacturers. 
The MCA considers that 
melatonin is a hormone which 




_._cal. 
Reflection 




has a physiological function 
and is therefore "medicinal in 
function". On this basis, it has 
classified it as a medicine and 
has warned manufacturers 
and retailers alike that it 
should not be sold until a 
product licence is granted. 
However, some manufacturers 
- and Pharma Notd in 
particular - dispute this 
classification and claim that, 
since melatonin is naturally 
present in many fresh foods, it 
is a food supplement. 

Who is right in law may 
eventually have to be decided 
by the courts. What is clear is 
that many products, 
melatonin included, are 
presently marketed under the 
guise of 'food supplements' 
when their use is obviously 
medicinal. 

Wild third party curative 
claims are made, often in the 
pages of the popular press, for 
products which rarely live up 
to the expectations of their 
desperate purchasers. 
However, they do achieve a 
very lucrative return for their 
producers without the 
inconvenience of having to go 
through the process of 
obtaining a product licence! 

I hope that this court case 
may clarify the medicinal 
status of 'food supplements', 



but even if it is non-definitive, 
the resulting publicity may 
attract sufficient political will 
to tackle a real legislative 
problem that at the moment 
allows the mavericks of a 
mainly responsible industry to 
exploit the gullibility of a lay 
public desperate for that 
'miracle cure'. 

A change 
for the better 
at Glaxo? 

Glaxo's agency scheme was 
introduced in order to bring 
this giant of the 
pharmaceutical industry 
closer to its customers. The 
result, for me at least, has 
been a complete disaster, with 
poorer discounts, more 
paperwork and non-existent 
presentation. Every purchase 
of a Glaxo product costs me 
money, so I just hope that the 
rumour of a change in the 
agency scheme is true (C&D 
July 13, p62). 

So far, Glaxo has 
disdainfully ignored all pleas 
for fair play and has continued 
to actively discriminate 
against the small 
independents. If you are a 
multiple chain of pharmacies, 
many goodies will flow out of 
Brentford, but, for me, the 
company remains an 
expensive luxury for whom it 
is more important to persuade 
local medical practices to 
adopt new asthma delivery 
systems than it is to service 
the local pharmacy. 

I would prefer that the 
agency scheme was scrapped 
altogether, but the rumoured 
change is far more likely. If 
that is true, then perhaps this 
time my welfare will be 
protected by Glaxo - and not 
penalised! 



CHEMIST & DRUGGIST 20 JULY 1996 



79 




IPTsnecials 



■■■■HI 




Salmeterol receives 
IOC approval 

Serevent (salmeterol) has be- 
come the first long-acting bron- 
chodilator to be approved by the 
International Olympic Commit- 
tee, a decision that will be wel- 
comed by asthmatic athletes 
c ompeting in this year's games in 
Atlanta. 

The drug was approved follow- 
ing evidence that it did nol 
enhance sporting performance. It 
is expected to benefit athletes on 
short-acting bronchodilators who 
do not want the risk of break- 
through symptoms and conse- 
quent compromised performance. 

The use of the drug is permitt- 
ed by inhaler only and the ath- 
letes must declare that they 
intend to take it by writing to the 
relevant medical authority prior 
to competition. 

Bayer launches new 
versatile lancets 

Bayer has launched a new type of 
lancet designed to fit any finger- 
pricking device for which lancets 
are prescribable. 

Baylet lancets (200-pack, basic 
NHS price S6.08), which are 25 
gauge for pain-free penetration, 
can now be dispensed against any 
prescription for blood glucose 
monitoring lancets. 

The new lancets solve the prob- 
lem for the phar macist of trying 
to match the appropriate product 
with the finger-pricking device 
the patient is using. 
Bayer Diagnostics UK Ltd. Tel: 
01256 29181. 



Sporanox now available 
as an oral solution 



Sporanox is now available as an 
oral solution containing lOmg 
per ml of itraconazole. 

The liquid has improved ab- 
sorption and enhanced bioavail- 
ability compared to the capsules 
and is indicated for oral and/or 
oesophageal candidosis in HIV 
positive and other immunocom- 
promised patients. The dose is 
200mg ( 20ml) daily to be taken as 
a single dose or divided into two 
doses for one week. Treatment 
should be continued for another 
week if there is no initial 
response. 

For resistant cases, 200-400mg 
should be given daily in one or 
two intakes for two weeks. If 
there is no response after that 
period, treatment should be 
extended for another two weeks. 



Sporanox liquid is recom- 
mended to be taken without food 
for maximum absorption. The 
liquid should be swished around 
the mouth before swallowing. 
The mouth must not be rinsed 
after swallowing. 

Sporanox liquid (NHS price 
£52.28) comes in 150ml bottles 
and is accompanied by a measur- 
ing cup. 

Janssen-Cilag has also launch- 
ed 60-capsule packs of Sporanox 
lOOmg (in addition to existing 
packs of four and 15) for patients 
needing long-term maintenance 
therapy, such as those with AIDS 
or prolonged neutropenia. The 
NHS price of the new packs is 
£89.84 

Janssen-Cilag Ltd. Tel: 01494 
567567. 



Videx given first-line indication for HIV 



Videx (didanosine, DDI) has 
received approval for use as a 
first-line adjuvant therapy in HIV 
infection. 

The close is 125mg eveiy 12 
hours for an adult under (iOkg 
and 200mg eveiy 12 hours for 
adults of 60kg and over. 

The approval was reached 
through a mutual recognition 
procedure across 15 European 
countries and is now awaiting 
the final seal from the Medicines 
Control Agency, which is ex- 
pected in the next few weeks. 

Bristol-Myers Squibb is cur- 



rently evaluating once daily 
administration of Videx and new 
formulations. 

Preliminary results of a US 
study presented at last week's 
international conference on 
AIDS in Vancouver found that 
combination therapy of didano- 
sine and stavudine (D4T) may 
have potent antiviral effects and 
that suppression of viral load is 
sustained for at least one year. 
The combination was also found 
to be well tolerated. 
Bristol-Myers Squibb. Tel: 0181 
572 7422. 



Seroxat (paroxetine) has been 
granted a licence for use in the 
prevention of relapse of panic 
disorder. The standard dose 
(40mg daily) for panic attacks 
should be used. Paroxetine is the 
only antidepressant in the UK to 
be licensed for both treatment 
and prevention of relapse of the 
disorder. 

SmithKline Beecham 
Pharmaceuticals. Tel: 01707 
325111. 

Glamin infusion solution 

Pharmacia & Upjohn has 
launched Glamin, an amino acid 
infusion solution containing 
supplemental glutamine. It is 
available in 500ml bottles at an 
NHS basic price of £26.38. 
Pharmacia & Upjohn Ltd. Tel: 
01908 661101. 

Wellcome interest 

Zovirax Cream 2g tube (POM) is 
now being distributed by Glaxo 
Wellcome UK, but the OTC packs 
of the tube and the pump will 
continue to be available from 
Warner-Lambert Consumer 
Healthcare. Dermal cream 30g, on 
the other hand, will no longer be 
distributed by Warner-Lambert 
but by Glaxo Wellcome only. 
Glaxo Wellcome UK Ltd. Tel: 
01270 508030. 

Kefadini singles 

All Kefadim (ceftazidime) vials 
are now supplied in single units. 
The new NHS basic prices are 
500mg/10ml, £4.95; 1g/20ml, £9.90, 
2g/50ml and 2g/100ml, £19.80. 
Eli Lilly & Co Ltd. Tel: 01256 
315000. 



MEDICAL MATTERS 



ooster for MMR introduced 



From October, all pre-school 
children will be offered a booster 
dose of the measles, mumps and 
rubella (MMR) vaccine. 

The second dose will be avail- 
able to children just before they 
start, school, alongside boosters 
of the diphtheria, tetanus and 
polio vaccines. It is expected to 
increase the protection of the 
first MMR given at 12-15 months 
and prevent the build-up of a 
large number of children suscep- 
tible to measles. 

To ensure no child is over- 
looked, the Department of 
Health is also organising a catch- 
up programme. This means that 



all children who were too young 
to be immunised in the 1994 
measles/rubella campaign, but 
who have already had their pre- 
school boosters by the time the 
MMR second close conies in, will 
be offered it. 

The catch-up programme will 
usually be run by general practi- 
tioners and call-up of children 
will be by health authority/Trust 
Child Health System computer 
unless it is initiated by the GPs 
themselves. 

The DoH will be supporting the 
new campaign with publicity 
material for the public and 
healthcare professionals. 



Hairy chest - a sign of intelligence? 



Hairy men should bare all and be 
proud. After all, it is a sign of 
intelligence, according to a study 
presented at last week's Con- 
gress of the Association of Euro- 
pean Psychiatrists in London. 

The study, conducted by Dr 
Aikarakudy Alias, of the Chester 
Mental Health Centre in Illinois, 
found a link between body hair, 
intelligence and academic ach- 
ievement in men. 

He found that 45 per cent of 
medical students in America 
were 'very hairy' compared to 
less than 10 per cent among the 
general male population. In 
India, medical students and engi- 



neering students were found to 
have more body hair than manual 
labourers and to achieve better 
results in their degrees than 
'smoother' colleagues. 

Menil.eisol MENSA also had a 
tendency to thick body hair, 
while some of the most intelli- 
gent men appeared to have haiiy 
backs as well as chests. 

Dihydrotestosterone, a variant 
of testosterone that is associated 
with male sexual characteristics 
and mental faculties, is thought 
to be responsible for the link. 

However, one famous excep- 
tion is Albert Einstein, who had 
no body hair at all. 



80 



CHEMIST & DRUGGIST 20 JULY 1996 



THERE'S NO MORE 
EFFECTIVE COMBINATION THAN 
MYCIL AND CLOTRIMAZOLE. 

Mycil Gold Clotrimazole contains 1% 
clotrimazole, one of the most effective athletes 
foot treatments available. 

And with your customers' confidence in 
the Mycil brand name, your recommendation 
will be reassuring as well as effective. 

So next time you're looking tor a 
treatment that's effective in more ways than one, 
remember Mycil Gold. 

It'll soon show athlete's toot a clean 
p. nr of heels. 

• i 

HHHj^HHHHjjSMUaHHfl Clotrimazole 1 % 

There's no better recommendation 
for persistent athlete's foot 



Product Information: Mycil Gold Clotrimazole 

Topical antifungal cream containing l% clol azoic, Use: Broad-spectrum antifungal cream 

I" 1 the treatment ol athlete's foot and other fungal infei tions mm h .is dhobic h. h, intertrigo, 
fungal nappy rash and ringworm. Contra-indications: hypersensitivity to any ol the 
ingredients Precautions: I lo no! use in or near eyes Not recommended foi use in 



pregnancy and lactation Dosage: Apply to the affected area think and evenly 2-3 times daily 
Side-effects: Karely, mild transient burning or irritation after applying the cream 
Packaging quantities: 20g tube. P (in box) RSP: £2.99. PL: 10622/000-1 Licence 
Holder: Dominion Pharm.i lid Haslemere, Surrey GU27 l|l ^fl^CROOKES 
Manufactured by: I ileh.im I le.ilth. .in I id Alton Hants CiU.W XJR ^ftU0f H 15 A I ,T1 1( 'A K K 



COUNTERDoints 



with Forehead-C 

Foreheatl-C is a new 
forehead-sized cooling 
sheet, said to soothe 
headaches and relieve 
fever in babies and young 
children. The active 
ingredient is super- 
hydrated aloe vera which 
has a cooling effect when 
placed on the forehead. A 
packet of three sheets 
retails at £1.99. 

According to Lina 
Trading, advantages of 
the products are that it is 
easy to apply, it provides 
instant comfort; aloe vera 
is good for the skin; and 
the sheet contains very 
little menthol (its vapours 
can irritate the eyes). 

Lina Trading is 
supporting the launch 
with a £60,000 television 
advertising campaign 
within London and the 
Home Counties area for a 
one-month period during 
September/October. 

The television 
advertisement will 
feature a Freefone 
number which viewers 
can use to obtain 
information about the 
nearest stockist. 
Mothercare will be 
stocking the product 
during the campaign and 
Lina is currently 
recruiting pharmacies 
within the area to do 
likewise. 

Lina Trading Ltd. Tel: 0171 
629 4144. 



Complete ad 
knocks juggling 



'Are you still juggling 
with a multi-bottle 
system?' is the catchline 
for Allergan Complete's 
£250,000 national 
consumer campaign. 

The month-long 
campaign includes full- 
page, colour 
advertisements in 
national newspaper 
magazines, including the 



Mail on Sunday's 
Night and Day, 
the Sunday Times 
magazine, and the 
Independent 
magazine. The 
Even in y Sta ndard 's 
ES magazine is also 
being included to give 
extra emphasis in the 
London area. 
Allergan group 




Colgate's added value Plax packs 



Colgate-Palm< ilive 
is running an 
added value 
consumer offer on 
Colgate Plax 
mouthrinse. 

An eye-catching 
neck collar on 
500ml slock will 
carry a money-off 
coupon towards 
the purchase of a 
Colgate Total 
toothbrush, 
prompting consumers to 
stock up across the 
Colgate range, and at the 
same time encouraging 
them to change their 
toothbrush regularly. The 
offer runs for two months 
and returns on the 250ml 
bottles from mid- 
September for a further 
two months. 




The collar also features 
the 'Plax Worx' message 
from the high-profile 
poster campaign, which 
will be back for a second 
burst during August. The 
campaign is part of a S 1 
million spend behind 
Colgate Plax this year. 
Colgate-Palmolive Ltd. 
Tel: 01 483 302222. 



Blisteze and Blistex give lips the kiss of life 



I >cniln Hi is suppi ii ling its 
cold sore brands - 
Blisteze and Blistex - 
with a national 
promotional campaign 
starting in September. 

Nearly ,S2 million is 
being invested in the 
campaign, which is set to 
run dining the winter 
months and feature on 
cinema screens, in the 
press and at point of 
sale. 

The campaign for 
Blisteze targets 15-24- 
year-< >lds with its 
'Blisteze - it's the cream' 
cinema commercial. The 
30-second advert will be 
seen on 1,,S()I) cinema 



screens from October to 
March next year, hitting 
over 50 per cent of the 
target audience. 
Advert ising with a 
similar theme will appear 
in teen magazines from 
September, backed by 
POS shelf wobblers. 

Similar campaign 
support for Blistex 
includes cinema and 
press advertising based 
on 'The Kiss of Life for 
Lips' theme. 

A counter display unit 
to hold all four products 
-Blistex Lip Cream SPF 
6, Blistex Ultra 
Protection Balm SPF 30, 
Blistex Lip Conditioner 



SPF 15 and Blistex 
Lip Tone SPF1 5- 
is also available to 
retailers. 

Aimed at 15-24- 
year-old females, 
the 30-second 
commercial will 
alternate 
fortnightly with 
the Blisteze 
commercial from 
I ictobct until 
March. Advertising 
will be targeted at 
the same magazines as 
Blistex. A red 'X' will be 
used on the counter 
display unit and 
showcard. 

Dendron is hacking the 



product manager 
Amanda Byrne says: 
"This high-impact 
consumer campaign will 
increase the visibility of 



Complete across the 
country. We believe 
many soft contact 
lens wearers still 
need to be told 
about the benefits 
of the one-bottle 
system. As 
Complete is 
available only 
from opticians or 
pharmacies, 
pharmacists 
should take full 
advantage of the 
campaign by stocking up 
now and ensuring 
Complete is highly 
visible to customers." 
Allergan Ltd. Tel: 01494 
444722. 



Water Gem for DIY filtering 



Aqua Cure, one of the 
UK's specialists in water 
purification, has 
launched a unique DIY 
home water filter system 
in response to 
consumers' health 
concerns about domestic 
water quality and safety. 

Water Gem is a ready to 
fit water filter kit, which 
can be easily installed to 
the domestic sink to 
provide clean, filtered 
water at less than one 
penny per litre. The filter, 
approved by the Water 
Research Council, is said 
to improve the taste and 
smell of tap water by 
filtering out sediment, dirt 
and rust, and reducing 
levels of chlorine, 
chemicals, herbicides 
and pesticides, as well as 



inhibiting scale. 

Water Gem retails at 
around £49.95 with a 12- 
month supply of easy-fit 
replacement filters at 
£29.95 for two. The 
replacement filters are 
also compatible with 
most other makes of 
domestic filter systems. 
The Water Gem comes 
with a three-year 
guarantee for all parts, 
excluding the 
replaceable filter and the 
company also provides a 
free helpline number for 
customers. Further 
information on the 
product can be obtained 
by dialling Freefone 0800 
627627 and asking for 
Water Gem. 

Aqua Cure pic. Tel: 01704 
501616. 




publicity package with a 
pharmacy competition 
based on matching lips 
to famous faces. The first 
correct entry opened on 
October 1 1 will win a 



midi hi-fi with 48 
runners-up receiving £30 
Marks & Spencer 
vouchers. 

Dendron Ltd. Tel: 01923 
229251. 



(MUST & DRUGGIST 20 JULY 1991 



• © « • 9 



From Practice 



i ••••»•••« ••••••••••••••••••••••• 

Win a 
major prize 



Is the professional service you offer from your 
pharmacy moving with the times? If you can relate 
how you are forging links with other healthcare 
workers, the Glaxo ^JeWcome/ Chemist & Druggist 
Community Pharmacy Award offers you an 
opportunity to win a major 




he way primary care is 
delivered is changing 
fast. The demarcation 
lines between the 
»sffe?o, healt h professions are 
breaking down and community 
pharmacy practice is adapting to 
the changes local purchasing is 
bringing. 

With this in mind, we want you 
to tell us how you are forging 
links with other health profes- 
sionals to the benefit of patients, 
others in the primary care team 
and your own business. 

You can enter the award if you 
practise as a community pharm- 
acist anywhere in the UK. You 
should explain, in an essay of 




The closing date for entries is 
July 31, 1996. 



The judges 



I 00(1 woids, how I he liaison you 
have forged was conceived, how 
it operates and the benefits it 
delivers. 

The following examples may 
serve as a guide to pharmacists 
wishing to enter: 
® you may be liaising regularly 
with your local GP practice to 
provide prescribing advice or 
diagnostic services 
• you may be co-operating with 



hospital pharmacists over med- 
ication for patients when they 
are discharged 

9 you may operate clinics, eg for 
diabetics, or offer services in 
conjunction with other health 
workers. 

You may include practice 
leaflets, other relevant literature 
and photographs to support your 
entry and illustrate an aspect of 
the service you offer. 



Entries will be judged by a panel 
of five judges. Glaxo Wellcome's 
Dr Maureen Devlin and C&D's 
editor, Patrick Grice, will be 
joined by: 

@ Ian Carruthers, chief execut- 
ive of Dorset Health Commission 

• Georgina Craig, who is the 

head of professional devel- 
opment at the National Phar- 
maceutical Association 
@ Gill Hawksworth, a comm- 
unity pharmacist and member of 
the Council of the Royal Pharm- 
aceutical Society. 

The prizes 

The opportunity to attend one of 
the major conferences or man- 
agement courses listed below 
will be offered to the three 
winning entries. 

• FIP 1997 

• Career Management Course 
( Raeburn & Keslake) 

• Managing Teams 

( Management Centre Europe) 

• Managing People (Manage- 
ment Centre Europe) 

• Strategic Decisions (Ashridge 
Management Centre) 

• ASHP Annual Meeting '96, 
San Diego, US. 



Please complet e the entry form below and attach it to the front of your entry. Send the complete 
entry to 'From Practice to People', Chem ist & Druggist, Miller Freeman Professional, Miller 
Freeman House, Sovereign Way, Tonbridge, Kent TN9 1RW. 



Name.. 



Registered Address 

Pharmacy Address (if different from above).. 



Postcode Telephone. 

Prizes in order of preference: 

1 



1 Entry is open to any pharmacist on the 
Register of the Royal Pharmaceutical 
Society of Great Britain or the Phar- 
maceutical Society of Northern Ireland, 
and who practises in the UK. 

2 The winning three entries as 
determined by the judges will be offered 
the opportunity to attend a major 
conference or recognised business 
management course with all expenses 
paid. No cash alternative will be offered. 

3 The closing date for entries is July 31, 
1996. The Award winners will be 
announced in Chemist & Druggist on 
November 9. Individual winners will be 
notified by post by October 10. 

4 The entry form below must 
accompany an essay of up to 1,000 
words setting out how and why the 
entrant considers the professional 
liaison developed by her or his 
pharmacy practice has improved 
healthcare provision to patients; 
benefited the business; and improved 
inter-professionallinks. 

; Practice leaflets, patient literature, 
photographs • and other supporting 
material Tnay be submitted with the entry. 

5 Entries should be typed or printed. 

6, The entry, and supporting material 
may be used editorially within Chemist 

6 Druggist, G&D cannot give an 
absolute guarantee that entries will be 
returned in their entirety, although 
every effort will be made to do so. 

7 Winning entrants should be prepared 
tn write an article for publication ol up 
to .1,000, words on the eortference/- 
j:bu§iness course/study tour they attend. 

8 The decision of the judges is final. No 
correspondence will be entered uiu>. 



CHEMIST &DRIGGIST 20 JULY 1996 



COUNTERPOINTS 



Eve Taylor claims 



in 



pharmacies 



Eve Taylor is launching its 
aromatherapy retail product range to 
over 14,000 pharmacies on August 1. 

Pure and blended essential oils 
will be made available to the 
pharmacy sector under the label of 
Face Care, Body Care, Specifics, 
Bath Oil, Hydrogels and 
Environmental Fragrance. Prices 
range from £4.50 for the facial 
cleansing brush to around £15 for the 
environmental fragrancing kit. 

Face Care will incorporate five 
products, No1 to No5, designed to 
help dry, sensitive, spot-prone and 
mature skin. 

3ody Care will consist of three 
products, No10 to No12, blended to 
stimulate and relax skin 
imperfections associated with fluid 
retention. 

The Specifics range includes three 
products (301 to 303) designed to 
assist the skin in its regenerative 
cycle. Specific 303 is recommended 
for scar tissue and stretch marks. 

Included in the Bath Oils range are 
six different oil-blends labelled 
stimulating, relaxing, toning, 
balancing, revitalising and soothing. 

Produced specifically for the retail 
market is the Moisturising Hydrogel 
range - Corelle, Citrelle and Astrelle, 
a facial cleansing brush and an 
Environmental Fragrancing range. 
The range consists of four kits 
energising, soothing, revite and 
refreshing - designed to release the 
vapour of blended oils through a clay 
diffuser. 

On-going support for the launch 
includes package brochures with an 
ingredient listing and application/- 
usage chart/guide, a sampling 
promotion and free product training. 
Pharmacies will be able to contact a 
helpline to obtain information for 
guidance on product specification, 
skin problems and ailments. 
Eve Taylor (London). Tel: 01733 
321101. 



Collection 2000 

Collection 2000 has created Shine 
Time 2000, a high-fashion look for 
autumn '96, combining shades of 
lilac, mauve, pearl, blue and silver. 

Fashionable combinations includi 
the Eyeshadow Trio No 97 (SI. 29), 
which consists of Mauve Sheen, 
Merlin and Flamingo Pink; or 
Quartet Eyeshadow No 7!). leal m ini: 
Seahaze, Diamond IJlue, Light Blue 
and Snowflake. A suitable lipstick 
for the look is ( lollection 2000 Lip 
i daze in < )rchid < lem (No 7) (SI. 15). 

( lollection 2000 products are nol 
tested on animals. 
Collection 2000 Ltd. Tel: 01695 50078. 



From A to Zinc with Arkopharma 




Arkopharma, the herbal 
medicine manufacturer, 
has launched a new multi- 
vitamin and mineral 
product - Azinc Complex 
capsules. 

The sugar-free product 
contains the recommended 
daily allowance of a range of 
vitamins and minerals from 
'A to Zinc'. These include 
beta-carotene (a precursor of 
vitamin A), vitamin C, 
vitamin E, vitamin B6, iron, 
magnesium, zinc, copper, 



folic acid and others. A pack of 
30 capsules retails at S3. 65. 

The new product has multi- 
coloured and white packaging 
to ensure on-shelf impact. 

Arkopharma says the 
supplement is "particularly 
effective for tired, stressed, 
overworked people; those 
who are slimming and have an 
unbalanced diet; or those who 
are regularly taking part in 
sporting activities". 
Arkopharma (UK) Ltd. Tel: 0181 
763 1414. 





* 5 c °™ Caps 

removal 

,,ls 'an/ Reset 
\ \ r\ £ 'fectri/e 





t savers 
for Profit. 

Summer Season Sales 

History shows both you and your customer alike 
can trust a product bearing the Carnation name. 
With this proven heritage Carnation Footcare 
.'ill help to make your sales grow. 





• 33V3% Profit on return 

• Full consumer advertising 
support throughout peak 
season beginning June '96 

75 years of proven pharmacy sales 





ARNATION 



Avail-able in packs ol 5 01 10 tram yon 
English Circuns representativi 



ABRIDGED INFORMATION. I EGA1 CATEGI IRY; I iSI INI Ml ATI! INS: l-oi the ri'iiinvnl «l hard. ■ ACTIVE INGREDIENTS: Sain ylu A, id BP 4.'". 

PRODUC1 LICENCE HOLDER: I uxson I Icrrard & I pany I imiU'd, 125 IWtwi-ll R.»id, ' >l.ll.ury, Warley, VK-m Midland*, B6 l ) 4BI li-l 0121 544 7117 

FURTHER INFORMATION FROM THt I ICENl I HOI DUR is AVAILABLE ON REQUEST. 



CHEMIST & DRUGGIST 20 JULY 1996 



85 



COUNTERPOINTS 



Strong growth in 
sun care sales 

The growing number of 
people taking sun 
holidays, and the hot 
summers we have 
experienced in recent 
years here in Britain, have 
contributed to strong 
growth in the sun care 
market, thought to be 
worth £136 million. 

A new market report 
from Datamonitor reveals 
that increased growth is 
coming from new product 
developments, particularly 
in the high-protection area, 
and that high sun protec- 
tion factor (SPF) items 
have increased their share 
of the sun care market. Sun 
protectors with an SPF of 7 
and above now account for 
48 per cent of the sun 
protection segment, while 
the share of SPF 0-3s has 
almost halved from 15.5 per 
cent in 1991 to its presents 
per cent. 

L'Oreal's Ambre Solaire 
is the market leader with 
a 5 per cent lead over 
Boots' Soltan. 

UK Skincare' is 
available at a price of 
£495 from: 

Datamonitor Europe. Tel: 
0171 625 8548. 



Dazzling campaign for Colgate Platinum 



Colgate-Palmolive is 
adopting a dazzling 
white theme for its 
integrated PR and 
press campaign for 
Colgate Platinum, its 
whitening toothpaste. 

All the activity is 
being targeted at women 
and includes 
advertorials in high- 
profile women's titles, 
such as Vogue, Marie 
Claire, Cosmopol ita n 
and Elle. The 
advertorials focus on the 




"whitening benefits 
which combine with the 
great taste to promise a 
pearly white, confident 



New 2 in 1 available for Synergie 



Synergie is building on its 
success in the cleansing 
market with the launch 
of a new combination 
cleanser and toner. 

Synergie Refreshing 
Gentle Cleanser Milk + 
Toner offers the 
efficiency of a milk and 
the benefits of a toner 
in a one-step, 
hypoallergenic 
formulation. 

The active ingredients 
inc lude mango oil, rich in 
essential fatty acids, 
which is easily absorbed 



by the skin to soften it. 
Vitamin E is added for its 
antioxidant properties, 
which the company 
claims helps protect the 
fatty membranes of the 
cells, delaying the 
appearance of fine lines 
and wrinkles. 

Synergie Refreshing 
Gentle Cleanser Milk + 
Toner is available 
nationwide from August, 
retailing at S3. 19 for a 
200ml pack. 

Laboratoires Gamier. Tel: 
0171 937 5454. 



Rapping with Ricola: going Alpine in Atlanta 



Ricola, the medicated 
herbal confectionery 
brand, is spending £5 
million on marketing 
support, which kicks 
off this summer with 
a heavyweight tele- 
vision campaign set 
to run throughout 
Eurosport's satellite 
coverage of the forth- 
coming Olympics. 

Valued at SI. 6m, 
the initial Olympic 
campaign will be 
televised daily bet- 
ween July 20 and 



August 4, and is expected 
to reach 1.2 million 
adults every day. The ad, 
featuring a futuristic rap 




group who solve their 
vocal problems with 
sugar-free Ricola, is a 
departure from the 
traditional Alpine 
image. 

Ot her marketing 
support includes 
public relations 
activity, point of sale 
material and space- 
saving pre-packed 
counter display units, 
available from 
leading wholesalers. 
Cedar Health Ltd. Tel: 
0161 483 1235. 



Braun improves comfort factor d !!kpi! system 



Next month, Braun is 
launching a further- 
improved Silk-epil hair 
removal system, called 
Silk-epil Comfort, which 
combines two new 
product features for 
enhanced comfort. 

Smaller tweezers are 
designed to provide 
gentler epilation by only 
gripping the hair to be 
removed, avoiding the 
unnecessary pulling and 



dragging of the 
surrounding hair and 
skin. 

Bigger feed-in combs 
smooth a larger area of 
the skin in preparation for 
the treatment, which also 
enhances comfort. 

Silk-epil Comfort EE110 
for Legs (£49.99) offers a 
choice of four settings, 
adjustable tweezer grip 
for normal or delicate 
hairs and Silk-epil After 



Epilation Moisturising 
Cream. 

The Silk-epil Comfort 
Body System (£49.99), an 
extension of the leg 
system, is an epilator with 
an interchangeable head. 
The tweezers can be 
replaced by a shaver for 
use on more sensitive 
areas, such as the bikini 
line or under the arms. 
Braun (UK) Ltd. Tel: 01932 
785611. 



smile and fresh 
breath". 

Supporting the 
advertorials, press ads in 
the same premium titles 



use a fashion theme to 
convey the 'teeth have 
never been so white' 
message. Models 
dressed in expensive 
white designer clothes 
wear an affordable white 
smile attributed to 
Colgate Platinum. 

To ensure the 'white' 
message hits home, 
cinema and video 
advertising will run 
through July and August. 
Colgate-Palmolive Ltd. 
Tel: 01 483 302222. 



Chocolate selection from Bourjois 



The autumn/winter colour 
collection from Bourjois 
is a palette of chocolate- 
coloured shades for eyes, 
cheeks, lips and nails. 

Available from 
September 4, the Bruns 
D'Automne collection 
spans the spectrum from 
Beige Rose Pastel 
Lumiere Eyeshadow 
(£3.95), a light iridescent 



beige, to Pastel Naturel 
Matt Eyeshadow in new 
Chocolat (£3.95), a rich 
mocha brown. 

New shades in Pastel 
Joues Blusher (£4.75) are 
Chatagne Doree, a 
shimmery bronze brown, 
and Santal, a coco brown 
with a hint of iridescence. 
Bourjois Ltd. Tel: 0171 436 
6110. 



ON TV NEXT WEEK 



Alberto-Culver V05: STV, C, A, HTV, W, C4 + satellite 

Alka-Seltzer: GMTV, C4 + satellite 

Andrews: All areas 
Aquafresh toothpaste: All areas 
Centrum: All areas 

Colgate-Palmolive Soft & Gentle: All areas 

Colpermin: M 

Gentle Touch: All areas 

Dettol Antiseptic spray: All areas, except CTV, C4, TSW 
Gentle Touch: All areas 

Gillette Natrel Plus: All areas, except LWT and GMTV 
Hedex Ibuprofen: All areas 

Macleans Bicarbonate of Soda toothpaste: All areas 

Nicotinell gum (trial pack): STV, B, G, Y, HTV, LWT, TT, C4 

Nurofen: All areas 

Oil of Ulay: All areas 

Pantene: All areas, except GMTV 

Radox Wheatgerm: All areas 

Rimmel: All areas, except U 

The Wrigley Company/Sugar Free Brands: All areas 

Total: All areas 

Wella Experience: All areas, except CTV 

Wrigley's Orbit (Improved): All areas 

GTV Grampian, B Border, BSkyB British Sky Broadcasting, 
C Central, CTV Channel Islands, LWT London Weekend, 
C4 Channel 4, U Ulster, G Granada, A Anglia, CAR Carlton, 
GMTV Breakfast Television, STV Scotland (central), 
Y Yorkshire, HTV Wales & West, M Meridian, TT Tyne Tees, 
W Westcountry 



C'9 



CHEMIST & DRUGGIST 20 JULY 1996 



...In fact, a massive £1.7 million in only six months 



We're investing hugely in the Blistex brands 
throughout the 6 months from September 
'96 with a lipsmackin' campaign including... 



Dlistex 



ceptional national cinema commercial with 'The Kiss of Life for Lips' theme 

citing heavyweight press campaign in the young female magazines with 
stunning full page, high-visibility ads. 

tremely impactful point-of-sale including eye-catching window displays. 

All this adds up to a major Xtra push for Blistex - giving a new 
Kiss of Life to your profits! 

For moisture, protection and everyday lipcare 




PHARMACYupdate 



Drugs in sport 

How some formulations can be 
abused to enhance performance 



Remember the 1988 
Olympics being 
overshadowed by the 
discovery that the 
world's fastest man, Ben 
Johnson, had anabolic 
steroids to help him 
across the finishing line? 
Well, in this Olympic 
year, Glasgow 
community pharmacist 
Stephen Kayne takes a 
look at what is and isn't 
banned for athletes 



The use of performance 
enhancing drugs in sport is 
not new. In 1865, canal 
swimmers in Amsterdam 
were accused of taking a 
mixture of heroin and 
cocaine, and in the ea r ly 
years of this century alcohol 
and strychnine were taken by 
boxers and a marathon 
competitor. 

Top athletes are often so 
caught up with striving for 
that extra margin of success 
that they may resort to any 
method that seems to bring 
this goal nearer. In some 
countries, drug abuse in sport 
may be routinely 
incorporated in elite training 
programmes. 

At the British 
Pharmaceutical Conference in 
London two years ago, the 
audience sat spellbound as an 
East German doctor 
systematically catalogued the 
programme of drug abuse 
that had been promoted by 
the authorities in his country 
before the fall of communism. 
He explained the practice of 
'drug holidays' where athletes 
ceased to take drugs at set 
periods before competition so 
that the risk of detection was 
minimised. 

Much of the initial work on 
drug testing in sport was 
accomplished by a 
pharmacist-run laboratory at 
King's College, London, 
where an International 
Olympic Committee- 



^ Needle exchange ^ Research digest 

Pharmacy-based needle exchange (IffS Predicting incorrect inhaler te 



Pharmacy-based needle exchange 
schemes come under scrutiny IV 



Jicting incorrect inhaler technique to 
reduce morbidity and mortality VII 




accredited drug testing 
service is provided for many 
national and international 
meetings'. 

Of the many classes of 
drugs available only a relative 
few have been implicated in 
enhancing performance or 
masking the use of banned 
drugs, and consequently 
placed on a banned or 
restricted list by the IOC. Here 
are some of the more widely- 
abused drugs. 

Stimulants 

Amphetamines 

Amphetamine sprays were 
originally prescribed for the 
treatment of nasal congestion 
(through vasoconstriction). 
They are powerful central 
nervous system stimulants 
and have been taken to 
increase the heart rate and 
allay inhibition before 
competition. Amounts of 14- 
21mg of amphetamine 
administered two to three 



hours before an event have 
been shown to improve 
performance in three-quarters 
of a sample of swimmers, 
runners and weight throwers . 

The drug causes blood to 
flow from the skin and is 
particularly dangerous during 
intense exercise in hot 
climates. There are numerous 
reports of cyclists suffering 
fatalities after taking 
amphetamines. 

Cocaine 
Amphetamines have largely 
been replaced in sport by 
cocaine, the regular use of 
which can lead to anxiety, 
agitation, insomnia and, 
ultimately, coronary occlusion 
and death. 

Sympathomimetics 
Adrenaline and the 
sympathomimetics, 
ephedrine and isoprenaline, 
are also considered to be 
stimulants and are banned. 

These compounds have 
many therapeutic 



THE COLLEGE OF 
PHARMACY PRACTICE 

This course (module 22), in 
association with multiple 
choice questions being 
published in c&d august 
10, provides 1 hour of 
continuing education 



|]:*I3HIIW 



To be aware of the problem 
of drug abuse in sport 

To recognise drugs on the 
banned or restricted list 

To understand how drugs can 
enhance performance in sport 

To be aware of OTC banned' 
and allowed' drugs 



applications, notably in the 
treatment of asthma, and 
together with some of their 
derivatives (for example, 
pseudoephedrine and 
phenylpropanolamine, etc) 
are often present in the 
formulas of OTC medicines, 
too - Aller-eze Plus, Lemsip 
Cold Relief and Day Nurse all 
contain banned ingredients. 

Salbutamol and terbutaline 
are permitted, subject to 
written notification by the 
team physician, but they may 
only be administered by 
aerosol. Sodium 
cromoglycate, used mainly to 
treat allergic asthma, is also 
allowed. 

Caffeine 
Caffeine produces a mild 
central stimulation. Maximum 
urinary levels of 12mg/ml are 
set by the IOC. 

The drug is claimed to 
counteract the reduction in 
performance caused by 
fatigue and is popular in 
rallying, particularly at night. 
It is thought to work by 
enhancing fat utilisation, thus 
sparing glycogen '. As few as 

Continued on Pll 



CHEMIST & DRliWilST 20 JULY 1996 



I 



Continued from PI 

four cups of filter coffee or six 
cans of a famous cola drink 
may cause a positive dope 
test. 

Anabolic steroids 

First used in 1954, anabolic 
steroids are mainly 
chemically-derived 
alternatives to the natural 
male hormone testosterone. 
They are designed to separate 
the anabolic and androgenic 
features of the hormone and 
to improve its availability. 

The drugs achieved 
spectacular notoriety at the 
Seoul Olympics in 1988 when 
Ben Johnson's gold medal 
was withdrawn after he tested 
positive for stanozolol. 

Anabolic steroids constitute 
nearly half of all positive 
samples detected by IOC- 
accredited laboratories. They 
are used to increase muscle 
mass, especially in the 
presence of high protein 
intake, as well as improving 
power and speed after 
intense physical training. 

There is some discussion as 
to whether they act directly 
on muscle tissue or whether 
they encourage muscle 
development indirectly by 
helping prolonged exercise. 
Performance may be 
enhanced by increased 
erythrocyte formation 
allowing an increased oxygen 
uptake. 

Side-effects include hepatic 
malfunction, coronary heart 
disease, cancer, sterility and 
uncontrolled aggressive 
behaviour 4 . 

An increased incidence of 
tendon damage has also 
been noticed among athletes 
taking anabolic steroids due 
in part to competitors 
neglecting accepted 
techniques within their 
chosen sport. 

Clenbuterol is a banned 
compound related to the 
anabolic steroids that was 'in 
fashion' for a time. It has 
been shown to stimulate the 
deposition of body protein in 
animals. 

However, drug testing has 
not proved to be foolproof. 
British athlete Diane Modhal, 
who originally tested positive 
for testosterone, was later 
cleared because of possible 
false results due to 
degradation of sample. 

Beta-blockers 

These drugs are used to 
lower blood pressure and 
slow the heart rate. Although 
they reduce the ability to 
perform physical exercise 
and are therefore not the 
subject of drug testing in 



endurance events, they help 
allay anxiety and steady the 
nerves, and therefore may 
help competitors in archery, 
darts, shooting, bowls and 
snooker. Side-effects include 
cold extremities, fatigue and, 
in extreme cases, heart 
failure. 

Diuretics 

Diuretics are sometimes used 
where a specific weight is 
needed - for example, with 
jockeys and boxers. Diuretics 
shed weight quickly by 
excessive water loss and by 
acting as a blocking agent to 
dilute urine and therefore 
prevent detection of drugs in 
other sports. Compounds 
such as acetazolamide, 
amiloride and triamterene are 
banned. 

Narcotic analgesics 

Included in this class are a 
number of drugs related to 
morphine. They are used as 
moderate to severe 
analgesics. 

The IOC Medical 
Commission believes there is 
evidence that these 
compounds have been 
abused in sport and, as there 
are many other non-narcotic 
drugs available, they should 
be banned. Over the counter 
products containing codeine 
should not be offered to 
athletes. 

Most of these drugs have 
major side-effects, including 
respiratory depression and 
dependence. 
Dextromethorphan and 
pholcodine are not banned 



and can be used as 
antitussives. 

Peptide hormones 

Human growth hormone 
(hGH) is naturally produced 
by the body to invoke 
maturation and physical 
development. It is now 
produced synthetically and 
may be used to increase body 
mass. Some male athletes 
use hGH to stimulate 
testosterone production, 
increasing aggression and 
competitiveness. As yet it is 
undetectable. 

A reverse approach is to 
use brake drugs, which are 
generally hormonal and are 
used to block physical and 
sexual maturation. They are 
very popular with female 
gymnasts. 

Other banned substances 
include human chorionic 
gonadotrophin 5 , 
corticotrophin (ACTH) and 
erythropoietin (EPO). 

The latter, a genetically- 
engineered substance, 
mimics the effects of training 
at high altitude by regulating 
the synthesis of erythrocytes, 
but in excess can cause fatal 
blood clots. Five years ago, 
the drug was blamed for the 
death of 18 German cyclists 
from circulation problems. 

The drug disappears rapidly 
from the body and detection 
has proved difficult in the 
past, but recently a new test 
has been announced. 

Other drugs are subject to 
certain restrictions. For 
example, alcohol and 
marijuana are not banned, 



Table 1: an example of a homoeopathic sports first aid kit 



Abrasions- superficial: 


Calendula ointment/cream 


Anxiety, excitement: 


Aconite (terror), Arrogant nit (anxiety) 




or Gelsemium (worry) 


Bruising: 


Arnica ointment 


Colds and flu: 


Gelsemium, Nelson's Coldenza, 




Weleda's Infludo 


Cough: 


Bryonia cough linctus (Nelson's) 


Diarrhoea: 


Argent nit (from anxiety), Arsen alb 




tablets 


Insect bites: 


Apis (stings) or Ledum (bites) tablets 




or pyrethrum spray 


Mental and physical tiredness: Arnica 


Motion sickness: 


Cocculus (or Nelson's travel sickness 




remedy) 


Soft tissue injuries: 


Ruta tablets or ointment 


Sunburn: 


Cantharis tablets (or Nelson's Burn 




ointment) 


Trauma: 


Arnica tablets 



but the presence of both can 
be tested. There are 
restrictions on the use of local 
anaesthetics and 
corticosteroids. 

Pharmacy advice 

Pharmacists must be vigilant 
when recommending OTC 
remedies. This is particularly 
important for elite and sub-elite 
athletes who may be subject to 
drug testing during training, as 
well as competition. 

Sports Councils in the UK 
produce handy cards listing 
the banned classes of drugs 
with examples, and a supply 
is available for customers. 
There is also a compre- 
hensive guide available, 
entitled 'Drugs and Sport'. It 
details all the banned and 
permitted products. 

Another solution is to 
recommend complementary 
remedies. The Sports Council 
warns that some herbal 
preparations may contain 
banned substances from 
naturally-occurring plants. For 
example, ginseng root does 
not contain banned 
substances, but it is known 
that marketed tablets (tablets, 
solutions, teas, etc) bearing 
the name 'ginseng' may 
contain other undeclared 
ingredients, such as 
ephedrine. The Olympic 
sprinter Linford Christie took 
ginseng some years ago and 
subsequently tested positive 
for a banned substance. 

There is no requirement for 
a comprehensive listing of 
ingredients in nutritional 
supplements making it 
difficult to determine whether 
doping regulations are liable 
to be breached. 

No such risk is involved in 
recommending homoeopathic 
remedies and they are not 
subject to any IOC controls. 
There is a range of about 30 
generic remedies known as 
'polychrests' that have a wide 
spectrum of activity and can 
be administered to 
sportspersons safely and 
effectively, without affecting 
any concurrent or subsequent 
treatment. Table 1 offers 
some suggestions for treating 
common problems. 

Discussions are in progress 
with the British Association of 
Sports Medicine to identify 
how pharmacists' 
contribution to sports care 
can be increased. 

References available on 
request. 

C&D is accredited by the 
College of Pharmacy Practice 
as a provider of distance 
learning material until 
December 31, 1997. 



II 



CHEMIST ft DRUGGIST 20 JULY 1996 



^ o re 2 ^ 5 7 ' 



j ™ s I \ 



> » £ _ 5 o g 1 

; 1 1 s § s f 

I Ifllfa 



l s ™ a s s g ° ' 

^J: ^ c II c j| ] 



3 u 

a ~» S c E 



QJ O V _ ^ 



?= "s ei a ! 

: 1 3 5 2 ? 5 

^||«.J|; 

i If lif| ] 



! S c 8 I „, I 



! i E £ 5 5 S» 
! a || 8 3 f g 



v * E 



Hills 

! a -E if> - o T 

■illai 

p c £ <u ^ - 



■ ' D 

a ; ? 



1=*? §1=11 i 



6 oj ct 11 ' I 

^ - i s ■ 



I S E g 




Amilamo 

Amiloride HCl Oral Solution, 5mg/5ml, Sugar Free 

New from Rosemont! 




I '"ILOHIDE HWWOCHt** 
ii ORAL SOLUTION 



Potassium Sparing Oral Liquid 

Now, when you have a patient who 
requires a potassium sparing diuretic, hut 
finds it hard to swallow tablets, you can 
offer them a solution ■ Ajtiilamont 

This is the latest addition to the 
Rosemont range of oral liquids, and is 
another unique product, being Britain's 
only licenced, single ingredient, 
potassium sparing diuretic, in oral liquid 
form 

Like many of Rosemont's products, 
Amilamont™ is sugar free, to help 
protect patients' teeth, it is suitable for 





Rosemont's Specials Service 

Under our specials licence we are able 

to offer you bespoke oral liquids, 
covering a wide range of therapeutic 
areas in a variety of strengths 
and sizes. 

Naturally, the products from our 
Specials Service are made to lull 
pharmaceutical standards, and are 
analysed and tested to ensure correct 
and consistent quality. 

These products can be supplied in as 
little as 24 hours upon request. 

Just call us on our 
FREEPHONE : LIQUIDS LINE 

0800 919312 



diabetics and is pleasantly flavoured to 
keep patients happy as well as healthy. 

Right Strength, Handy Size 

Amilamont™ is at a strength of 
5mg/5ml, making if easy to administer a 
standard dose*. It is available in a handy 
125ml, tamper evident bottle, from all 
major wholesalers 

With Amilamont™ added to the 
licenced liquid range, Rosemont 
continues to give pharmacists a lop 
quality way to treat patients, without 
taking unnecessary responsibility.. 

*BNF March IHflli 

Filled with confidence! 

As Britain's oral liquid ROSGITIOnt'S 

medicine specialists, Rosemont - ■ - - 

are keeping at Hie forefront of HGW rllCfll Sp00O 
production technology. DrOdUCtiOII line 

Rosemonl has installed a complete new 
filling line as part, of the multi-million 
pound improvement to their 
manufacturing facilities. High speed 
bottle filling is combined with optimal 
precision to volume, ensuring that high 
quality liquids are processed into ready 
to use products with the latest 
technology. 

Staff are sent, to Germany and Italy for 
training in the operation and servicing of 
one of the most modern filling lines 
currently in use in the UK. 

This major investment is part of 
Rosemont's ongoing development, 
programme, designed to ensure that, they 
will continue to offer pharmacists and 
patients the very finest range of oral 
liquid medicines in the country. 




< M % . 

The new compounding fj|jp| 
and filling line at- 
Rosemont. 



The LICENCED LIQUIDS 




Current oral liquid medicines in the Rosemont range, fully licenced and prepared to 
the highest quality standards: 

• Nuslamont™ Nystatin Oral Suspension, 100,000iu/ml, Sugar Free - PL 0427/0)01 

• Temazepam Oral Solution 10mg/5ml, Sugar Free - PL 0427/00X9 
IBB ' IfE • Miihadose 1 " Methadone Oral Concentrate, lOmg/ml. Sugar Free ■ PL 0427/0098 Ais ,, I: ■ > „ / • 
WKtJ^^ ' Amilamonl' ' Amitoritlv IICI Oral Solitlioi, inig/tiiul. Sugar Free - PL 0427/0091 //Of/ ((til I' (' I If (HI 



Rosemont Pharmaceuticals Ltd., 

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LSI 1' 9XE Telephone: (01 13) 244 1400 Fax: (01 13) 246 071 



PRACTICE 




wop shop 



Pharmacy needle exchange schemes are now 
widespread thanks to their role in reducing the 
transmission of HIV among injecting drug abusers. 
Dr Rod Tucker, a community pharmacist and director 
of the Freelance Needle Exchange scheme in North 
East Lincolnshire, investigates how pharmacists can 
make the most of the scheme 



N'eedle and syringe 
exchange is simply a 
scheme enabling injecting 
drug users to obtain free 
sterile needles and syringes 
in exchange for their used 
ones. 

Exchange schemes were 
originally established in 1984 
in Amsterdam, not in 
response to the emerging 
AIDS epidemic, but to the 
growing problem of hepatitis 
B among drug injectors. 

Although the HIV virus had 
been isolated as early as 
1981, little was known about 
its mode of transmission. 
However, in 1983, blood 
samples taken from drug 
injectors in Edinburgh were 
the first to show positive 
antibodies to the HIV virus' 
and studies of drug injectors 
have since found that the 
microtransfusion of blood 
which occurs when drug 
injectors share syringes poses 
a significant risk for the 
transmission of the virus 234 . 

Moreover, it is known that 
injectors will share spoons, 
filters and bowls of water, and 
communal use of such 
paraphernalia is thought to 
pose a risk in the 
transmission of the virus 5 . 

Government policy 

The UK Government 
responded quickly to the 
issue of HIV prevention and, 
in 1987, exchange schemes 
were officially launched. The 
remit of these exchange sites 
was to issue injecting drug 
users with sterile syringes, on 
an exchange basis, so that 
used injecting equipment 
could be disposed of safely. 
Before this official launch, 
schemes to supply drug 
injectors with clean syringes 
had already been running 
through various drug 
agencies 6 . 

In Liverpool, some 
pharmacists were distributing 
free needles, syringes and 
condoms, and were accepting 



back used syringes for safe 
disposal'. 

The sale of syringes by 
pharmacists to known or 
suspected drug misusers was 
initially denounced by the 
Royal Pharmaceutical Society 
which, in 1982, had issued a 
Council statement stipulating 
that sales of syringes should 
only be permitted for bona 
fide customers for therapeutic 
purposes. However, by 1986 
the Society had lifted this 
restriction and issued 
guidelines for pharmacists 
wishing to become involved 
in exchange schemes 8 . 

Aims of the scheme 

In response to the growing 
AIDS epidemic, the mid-1980s 
saw a wider acceptance of the 
concept of harm 
minimisation. This 
represented a pragmatic 
approach to drug misuse and 
involved two basic tenets: 
reduce the risk to the 
individual who injects drugs 
and minimise the harm 
associated with the misuse of 
drugs. 

In the context of harm 
minimisation, needle 
exchange schemes are 
considered to be more than 
simply a means of supplying 
clean injection equipment. 
They are a strategic response 
to the potential rise in the 
prevalence of AIDS and a 
means of making contact with 
as many drug injectors as 
possible in an effort to 
change their AIDS-related risk 
behaviour, such as sharing 
syringes and filters, for 
example. 

To achieve this aim, 
exchange schemes need to be 
in a position to offer a wide 
range of drug paraphernalia, 
such as medicated swabs, 
tourniquets, sterile water and 
filters. During the past ten 
years, exchange schemes 
have become accepted as an 
important harm reduction 
measure 9 ' . 





THE COLLEGE OF 
PHARMACY PRACTICE 

This course (module 23), in 
association with multiple 
choice questions being 
published in c&d august 
10, provides 1 hour of 
continuing education 



Pharmacy-based exchange 
schemes are designed to be 
complementary to the 
services offered by drug 
agencies and should be 
viewed as a means of making 
contact with a large number 
of clients and, if necessary, 
referring those clients to drug 
agencies where there is 
access to advice and 
counselling about their drug 
use. 

There are several reasons 
why pharmacies should 
provide needle exchange 
services. Accessibility and 
anonymity are key 
advantages of community 
pharmacies. Much of the 
early needle exchange 
research found that drug 
injectors would not travel any 
great distance to obtain their 
syringes or 'works' and many 
clients still feel there are 
barriers to using agency- 
based exchange schemes. 

Pharmacies also tend to 
have longer opening hours 
and many are open on 
Sundays. Moreover, 
pharmacists are available to 
offer advice about general 



O To understand the principles 
of needle exchange schemes 

To be aware of Government 
support for such schemes 
C To recognise how schemes 
can be put into practice 

To recognise the aims of a 
pharmacy-based scheme 

To appreciate the associated 
moral and ethical dilemmas 



health matters and, provided 
they respond to drug injectors 
in the same way as any other 
customer, a degree of trust is 
soon built up. 

Practicalities 

Pharmacy needle exchange 
schemes are now widespread 
in the UK and the 
Pharmaceutical Services 
Negotiating Committee has 
information about schemes in 
over 60 unitary health 
authorities", though in theory 
every authority has funding 
available. The pharmacy 
schemes are often co- 
ordinated by a local drug 
agency, but in some areas the 
health authority will appoint a 
needle exchange worker. This 
is sometimes a pharmacist 
who can visit pharmacies 
with training and advice. 

Alternatively, as 
pharmacists are the providers 
of exchange services, it would 
seem logical for them to 
amalgamate and co-ordinate 
the needle exchange scheme 
themselves. This latter option 
is the model for the Freelance 
needle exchange scheme in 
North East Lincolnshire. The 
scheme is managed by 

Continued on PVI ► 



IV 



CHEMIST &. DRUGGIST 20 JULY 1996 



Excessive perspiration is 
deeply embarrassing and 

now we're telling 
everyone about it?9 



What if you couldn't find an 



As many as 26% of all women asked 



antiperspiranl that worked? What if were interested in buying a product 

you went on sweating so much successfully used by doctors' - if it 

that before the day was out you was available from their pharmacist, 

needed a change of clothing? This is Clearly the market is there, and 

the reality for a surprising number Driclor Solution is ihe brand to 

of people, as a recent Gallup survey reach it especially once our 



found. In fact, 11% of the women 



edia campaign begins this 



they spoke to were frequenth forced summer. \s a c 



iperspirant 



to change clothes or <o\er up ^ 




to avoid the embarrassme 



Kcessive perspiration. 
The level of dissatisfaction 
with existing antiperspirants 
might also surprise yon. 



Driclor 



SOLUTION 



(Ontmrc Aluminium Chloride Htunhydiolo 

A major 
advance in 
the treatment 
of excessive 
perspiration 



Driclor Solution provides long 
term control of excessive 
perspiration, and even works 
for problem sweaty feet. 
Every pharmacist should 
stock it. Now more than ever. 



5 



EFFECTIVE DRYING ACTION 



• ICING LASTING EFFECT 
• UNPERFIMT1 



ROll OH APP1K ATOK 




Pharmacy only clinical anli|>ci s|>ii ayS 



Presentation: Solution \ctlvc ingredients: Aluminium Chloride Hexahydrate USP areas are completely «ir\ before application Do noi apply Driclor to broken, 

20% w/w Uses: Driclor is Indicated for the treatment of hyperhldrosis (excessive Irritated, or recent l> shaven skin Dru inr may r.-msc irritation which maj be 

perspiration) Dosage and administration: Apply Driclor lasi thing al night after alleviated by the use ol a weak, corticosteroid cream \void contact with the eyes, 

drying the affected areas carefully Wash oil in the morning. Do noi re-applj the There are no restrictions on 1 1 ■ < - use ui Driclor during pregnancy or lactation. Avoid 

^1 product during the day Initially the product may be applied each contact with clothing and polished metal surfaces. Product Licence Number: 

5TIEFEL rii^hl until sweating slops during the day. Frequency of 0174/004'! Pack si/e and Retail Selling Price: 30ml bottle. £4.75. Legal 

\ application may then be reduced to twice a week or less category: P. Date ol preparation: March 1995 Stiefel Laboratories (I'M Ltd., 

fterarch in Dermatology Contra-indieations, warnings etc: Ensure that the affected llollspur Lane. Wooburn Green, High Wycombe, Bucks, 11P10 0AU. 

I 



PRACTICE 



J Continued from PIV 

myself and another 
pharmacist and we were 
successful in our bid for the 
needle exchange services 
which were put out to tender 
in 1993. Today, we have 
ultimate control over 
providing needle exchange 
services in the region, liaising 
closely with the local 
substance misuse agency and 
providing training for 
pharmacists and information 
for exchange clients. 

The range of possible 
equipment that can be 
supplied through pharmacy 
exchange schemes is listed in 
Table 1. Some pharmacies 
supply syringes loose while, 
in other areas, equipment is 
supplied prepacked. 

Few of the pharmacy 
schemes will supply filters, 
tourniquets, citric acid or 
sterile water since the supply 
of such paraphernalia (other 
than syringes and needles) is 
an offence under the Misuse 
of Drugs Act. In practice, it is 
unlikely that the police, who 
are generally supportive of 
exchange schemes, will bring 
about a prosecution. 

Furthermore, the Code of 
Ethics cautions pharmacists 
on the supply of substances 
"liable to misuse". The sale of 
citric acid and supply of filters 
or tourniquets could 
constitute a breach of the 
code. 

There is considerable 
variation throughout the 
country in both the allocation 
of funding for exchange and 
how pharmacists are 
remunerated. As a broad 
generalisation, pharmacists 
are paid a fee per issue, 
whether that is a single 
syringe or a pack, and an 
annual retainer fee which is 
paid for providing the service, 
irrespective of the number of 
exchanges made. The fee is 
sometimes incremented on a 
sliding scale and payments 
vary between a maximum of 
£6,000 per annum and a 
minimum of £50 per annum. 

Morals and ethics 

There is a moral dimension to 
the concept of supplying 
syringes to drug injectors 
which often presents 
pharmacists with a dilemma. 
To supply syringes would 
appear to condone drug 
misuse, whereas not to 
supply syringes increases the 
likelihood that drug injectors 
will share syringes and hence 
expose themselves to the risk 
of HIV infection. 

While this might be 
perceived as the drug 
injector's just desserts, the 



Table 1: range of possible equipment 
available through exchange 
schemes 



Various syringes (eg 1,2,5 and 10ml) 

Medi cated swabs 

Condoms 

Intercobra tubes (to return used syringes) 
Spermicides 



Tourniquets 



Sterile water 



Citric acid 



Cotton wool/filters 

major route of transmission 
of the virus is through sexual 
intercourse and drug users 
are known to be sexually 
active and indulge in 
unprotected sex' 1 . This clearly 
has implications for the 
spread of HIV into the wider 
population and pharmacists 
should bear this in mind 
before rejecting the idea of a 
needle exchange scheme. 

There are also several 
practical issues to be 
addressed (see Table 2) and it 
is well worth doing some 
research into the drug 
problems in an area to assess 
the need for a needle 
exchange service. Many of 
these concerns can be 
alleviated by talking to other 
pharmacists who are 
currently involved in 
exchange schemes. 

Shoplifting and physical 
abuse are rarely a problem 
(although they may occur) 
and such actions are 
perpetrated by the minority of 
clients as most exchange 
clients value the service and 
are unlikely to act in such a 
manner as to jeopardise it. 

Another factor which poses 
a problem is the risk of 
needle-stick injuries. Existing 
schemes will have a policy on 
the use of sharpsafe boxes. It 
is sensible to store such 
boxes where they can be 
easily accessed, but not 
where they may cause 
inconvenience (or risk) to 
other members of staff or 
public. Collection of the 
sharpsafe boxes is normally 
arranged by the local 
authority. 

If any pharmacist 
does sustain an 
injury, provided that 
they have observed 
the protocols 
already in place, it is 
unlikely that they 
would be held 
legally liable and 
hence have to pay 
compensation. 
Furthermore, if a 
pharmacist causes 
an injury to a 
member of the 



public, then they 
would be covered 
by their insurance 
(for example, NPA 
insurance). 
Alternatively, if the 
pharmacist causes 
injury to another 
member of staff, 
then they are 

covered by the 

employer's 

insurance. 
Pharmacists are 
also strongly 
advised to get 
themselves and 
their staff vaccinated against 
hepatitis B. 

Despite many of the 
reservations that pharmacists 
might have about needle 
exchange schemes, the 
majority who are already 
involved find it is a satisfying 
part of the extended role and 
that it has not adversely 
affected their business. 

While the direct financial 
rewards can be low (though 
up to £6,000 per year is not 
inconsiderable), in the longer- 
term many of the exchange 
users will use their exchange 
pharmacy to collect their 
prescriptions, so generating 
greater revenue. 

Pharmacists who are 
interested in becoming 
involved should contact their 
LPC or the local drug agency 
which will be able to advise 
them on the availability of 
services in their particular 
area. 

Future schemes 

In the future it is conceivable 
that pharmacists will become 
more involved in the 
provision of services to drug 
misusers, including anabolic 
steroid users. There are 
already schemes in parts of 
the country which involve the 
supervision of methadone 
and it is possible that 
pharmacists could play an 
even greater role in the 
clinical management of these 
patients. 

The recently published Task 
Force review on services to 
drug misusers 1 ' foresees a 
greater role for pharmacists, 
and with the Government 



Table 2: possible reservations of 
pharmacists before starting needle 



Increased shoplifting 
Adverse effect on business 
Staff objections 
Risk of needle-stick injury 
Threat of physical/verbal abuse 
Level of remuneration 
More needles discarded in the community 



prepared to allocate 
additional money for projects 
related to substance misuse, 
pharmacists should waste no 
time in taking the initiative to 
define how best they can 
extend their role in the area of 
service provision. 

References 

Mulleady G. A review of 
drug abuse and HIV infection. 
Psychology and Health 
1987,1.149-63 

2 Robertson J R, et al. 
Epidemic of AIDS-related 
virus (HTLV lll/LAV) infection 
among intravenous drug 
abusers. BMJ 1986; 292: 527- 
29. 

3 Wodak A, et al. Antibodies 
to the immunodeficiency 
virus in needles and syringes 
used by intravenous drug 
abusers. The Medical 
Journal of Australia, 
1987;147:275-76. 

4 Chitwood D D, et al. HIV 
seropositivity of needles from 
shooting galleries in South 
Florida. American Journal of 
Public Health 1990,80(2): 150- 
52. 

5 Koester S, Booth R, Wiebel 
W. The risk of HIV 
transmission from sharing 
water, drug mixing containers 
and cotton filters among 
intravenous drug users. The 
International Journal on Drug 
Policy 1991;1(6):28-30. 

6 Lart R, Stimson G V. 
National survey of syringe 
exchange schemes in 
England. Br J Addiction 
1990;85:1433-43. 

7 Anonymous. Liverpool 
pharmacists supply free 
needles and condoms. Pharm 
J 1986; 237: 825. 

8 Council Guidance. 
Guidelines for pharmacists 
involved in schemes to 
supply clean syringes and 
needles to addicts. Pharm J 
1987;238: 481. 

S Advisory Council for the 
Misuse of Drugs. AIDS and 
Drug Misuse Part 1. HMSO, 
London 1988. 

10 Advisory Council for the 
Misuse of Drugs. AIDS and 
Drug Misuse Update. HMSO, 
London 1993. 

11 Horridge G, PSNC. 
Personal communication, 
February, 1996. 

12 Quirk A, Rhodes T, 
Condom use by drug users: 
whether, why not and how? 
Executive summary No41, 
CRDHB, London; 10995. 

13 Task force on the services 
for drug misusers, HMSO, 
London, 1996. 

C&D is accredited by the 
College of Pharmacy Practice 
as a provider of distance 
learning material until 
December 31, 1997. 



Mi 



CHEMIST & DRUGGIST 20 JULY 1996 



Predicting 
incorrect 
inhaler 
technique 




Given that asthma and 
chronic obstructive 
airways disease cause 
significant morbidity and 
mortality, and that metered 
dose inhalers are the 
standard means of delivering 
bronchodilator therapy, we 
ought to know more than we 
do about the ability of 
individuals to use the devices 
correctly. A group of US 
pharmacists have, with Glaxo, 
now addressed the problem. 

They studied 29 people 
attending hospital clinics who 
were prescribed an inhaler for 
the first time and 42 healthy 
volunteers with little or no 
previous experience of 
inhalers. Their average age 
ranged from 50 to 87 (mean 
70). Each was given 
standardised instruction on 
inhaler technique using a 
placebo device. Correct 
technique was defined as 
activating the device within 
the first half of inhalation; 
continuing to inhale slowly 
and deeply; and holding the 
breath at full inspiration. 



Assessment of inhaler 
technique was then correlated 
with variables which might 
influence performance. 

Overall, 62 per cent of all 
subjects could demonstrate 
the correct inhaler technique 
after instruction and 56 per 
cent could still do so one 
week later. There was no link 
between the time taken to 
learn the technique and 
ability to use the inhaler 
correctly, with half the 
successful users needing 10 
20 minutes and one in eight 
needing 20 30 minutes to 
master the device. Variables 
that were significantly 
associated with incorrect 
technique included cognitive 



impairment, male gender and 
lesser hand strength. 
Adjusting for hand strength, 
those with cognitive 
impairment were 3.7 times 
more likely, and men were 
five times more likely than 
women, to have incorrect 
technique. Factors that did 
not predict incorrect 
technique included 
educational status and being 
a patient or volunteer: those 
with incorrect technique 
tended to be older but this 
was not significant. 

These results are 
informative: advanced age is 
usually assumed to be one 
explanation for not being able 
to use an inhaler but, in itself, 



this appears not be so. 
Nonetheless, many of the 
problems sometimes 
associated with old age and 
drug treatment in the elderly 
- cognitive impairment, weak 
hands - are important. It is 
surprising that men were less 
able to use inhalers correctly; 
this may be due to poorer 
manual dexterity compared 
with women. The factors 
identified in this study are 
easy to use clinically as 
indications that some patients 
may need extra help with 
their inhaler and they should 
be borne in mind when 
counselling patients. 
Archives of Internal Medicine 
1996;156:984-8 



Insight into schizophrenia treatment 



For many people with 
schizophrenia, if they are 
to live in the community 
and carry on a near-normal 
life, it is important that they 
are encouraged to take their 
medication. Yet discontin- 
uation seems common, 
resulting not only in symptom 
recurrence but also disrupting 
social and economic support. 

One reason why affected 
people may stop taking 
antipsychotic medication - 
apart from the adverse effects 
- is that they may not believe 
they need it. There is evidence 
that only one-quarter of 
people with a long history of 
psychiatric illness believe they 
are psychiatrically ill 



In particular, people with 
schizophrenia may not be 
aware that they are ill, that 
their illness causes 
symptoms, or that they need 
treatment. Whether this lack 
of insight is due to 
schizophrenia itself is 
uncertain but it has been 
linked with a belief that 
treatment is unnecessary and 
with a wish to stop 
medication. Conversely, 
patients with insight into their 
problems are more likely to 
co-operate with treatment. 

Other factors which might 
influence the decision to stop 
treatment include knowledge 
about schizophrenia and 
intellectual functioning. How 



they interact with insight has 
now been investigated in 64 
people with schizophrenia. 

Their keyworkers (health 
professionals designated to 
co-ordinate care for 
individuals) noted that nine 
actively requested 
medication, 40 passively 
accepted it and 15 actively 
refused treatment. Insight 
was strongly correlated with 
illness severity and chronicity. 
Those who had actively 
refused medication within the 
previous two weeks had 
significantly less insight than 
those who had accepted it. 
Insight correlated with years 
in education and educational 
attainment but not with IQ; 



and education about 
schizophrenia significantly 
increased insight. 

Although it is difficult to 
define insight scientifically 
(one definition of lack of 
insight is disagreeing with the 
psychiatrist!), it appears that 
initiatives that improve 
awareness and understanding 
of schizophrenia should 
improve continuation with 
medication. Although 
intellectual function (as 
denoted by IQ at least) does 
not appear to be relevant, 
these initiatives must be 
modified for people with 
poorer education. 
British Journal of Psychiatry 
7996,168:7 18-22 



CHEMIST & DRUGGIST 20 JULY 1996 



VII 



"ash incentives for prescribers 



A cash incentive may or may 
1 1 not encourage GPs to 
I .^prescribe more cheaply 
but it is only one of several 
determinants of prescribing, 
say researchers in Newcastle. 

They surveyed local 
practices after GPs were 
offered an incentive scheme 
to cut prescribing costs which 
would have earned each GP 
principal £1,000-£2,500 to 
spend on approved 
development projects. 

In the former Northern 
Regional Health Authority, 
323 non-fundholding 
practices completed a 
questionnaire on the factors 
that affected their prescribing. 
Just over half reported that 
they had tried to achieve 
target savings. The decision 
to achieve this was usually 
reached within the practice, 
though some said that 
professional opinion and the 
size of the financial incentive 



were also important. Of these 
practices, however, two-thirds 
did not meet their target, 
saying it was not achievable, 
there was insufficient time or 
the reward did not justify the 
effort. 

Medical and pharmaceutical 
advisers helped 40 per cent of 
practices with advice about the 
incentive scheme. Most 
practices decided to achieve 
their targets by increasing 
generic prescribing, but a third 
reconsidered the duration of 
treatment they prescribed and 
a quarter increased recommen- 
dations for self-medication. 

Only 31 per cent said they 
had a formulary or 
prescribing policy, though 
when one was in place 
adherence to it was high. 
Treatment guidelines were in 
place in over 50 per cent of 
practices for asthma, diabetes 
and hypertension. The only 
guideline that was 



significantly more likely to be 
found in practices which 
achieved their targets was for 
the management of ischaemic 
heart disease. Guidelines 
were more often followed 
'usually' than 'always'. 

Hospital practice is a 
potentially important 
influence on GP prescribing. 
Schizophrenia, diabetes and 
ischaemic heart disease were 
identified by more than 50 per 
cent of practices as conditions 
for which prescribing was 
usually or always hospital- 
led. Around 40-50 per cent of 
practices considered the 
treatment of asthma, peptic 
ulceration and hypertension 
as predominately hospital- 
led. Conditions least often 
influenced by hospital 
practice were contraception, 
constipation, osteoarthritis 
and acute infection. 
British Journal of General 
Practice 1996,46:287-90 



Co-operation for a formulary 



<n Ps who develop a 
| ^-formulary benefit 

U considerably from the 
exercise - not only through 
more rational and often 
cheaper prescribing but also 
by revising their knowledge of 
therapeutics. However, the 
process is very time- 
consuming and often 
unwelcome. Buying-in 
someone else's formulary 
avoids the work but leaves GPs 
with no sense of participation 
and little interest in keeping to 
the recommendations. 

GPs in South Bedfordshire 
have investigated whether 
these problems can be 
overcome by sharing the 
work among more GPs but 
keeping the initiative local by 
restricting it to the district. 
From Bedfordshire's 350 GPs, 
50 agreed to work together, 
taking advice from specialists 
and a pharmacist. They based 
their work on three published 



formularies and met once- 
monthly to review products 
for inclusion. The final 
formulary, designed to meet 
80 per cent of a GP's needs, 
contained 179 drugs (72 per 
cent generic) and delivery 
devices from 12 therapeutic 
categories. 

The effect of the formulary 
over three years was 
evaluated by comparing 
prescribing by the 50 
participants with the 300 local 
GPs who did not take part. 
Generic prescribing increased 
both among participants 
(from 44 to 51 per cent) and 
non-participants (40 to 48 per 
cent). Significant changes 
among formulary users 
occurred in three therapeutic 
categories: cardiovascular, 
musculoskeletal and (for one 
year only) obstetrics and 
gynaecology. The number of 
items per prescribing unit 
increased by 11.8 per cent 



among participants compared 
with 14 per cent in non- 
participants. Before the 
implementation of the 
formulary, participating 
practices spent £1 1,000 less 
on drugs than other practices 
per quarter; afterwards, the 
difference increased to 
£51,000. The cost of 
developing the formulary and 
auditing its effects was 
estimated at £70,000. It would 
break even after six months. 

It is difficult to identify 
trends in prescribing practice 
in that context but the 
formulary appears to have 
had a positive impact on 
prescribing. The 50 GPs 
involved spent £1.3 million on 
drugs in the first quarter of 
1994 and the authors note 
that even small changes in 
practice have a significant 
impact on costs. 
British Journal of General 
Practice 1996;46:271-5 



Antibiotics 
in hospitals 



/^Vver-use of antibiotics is one 

|of the biggest problems 
\J pharmacists tackle. It 
wastes money; increases the 
risk of antimicrobial 
resistance; and increases the 
risk of adverse reactions. 
However, a seven-year study 
from a Utah hospital shows 
that, with effective 
intervention, substantial 
improvements in antibiotic 
use can be achieved. 

Activity data is routinely 
recorded at the hospital, 
providing clinical and financial 
data which can be fed back to 
prescribers via a 
computerised information 
system. The computer 
software supports an expert 
system which provides 
computer-assisted decision 
support and this was used to 
develop consensus guidelines 
on antibiotic prescribing. 
Prescribers used the computer 
model to rationalise their 
treatment decisions. Each 
received feedback on 
prescribing decisions and this 
was found to be critical to the 
system's success. 

Of the 162,000 patients 
discharged from hospital 64,000 
received antibiotic therapy. 
There were significant 
improvements in the quality of 
surgical prophylaxis: the 
proportion of patients receiving 
their pre-operative dose within 
two hours of surgery increased 
from 40 per cent to 99 per cent 
and the mean number of 
prophylactic doses given per 
patient decreased from 19 to 5.3. 
Throughout this period, 
prophylaxis was provided with 
only three cephalosporins - 
cefazolin, cefoxitin and 
cefuroxime. 

In 1986, prescribers' choice 
and the computer guidelines 
conflicted an average of 2.67 
times per day and treatment 
was changed in 30 per cent of 
cases. By 1994, there was an 
average of 1.32 conflicts daily 
and 99.9 per cent were 
changed to match the 
computer's recommendation. 
Annals of Internal Medicine 
1996;124:884-90 



PHARMACYupdate: distance learning for pharmacists 



Pharmacists using Pharmacy 
Update for continuing education 
are reminded of the need to test. 
With the support of Johnson & 
Johnson MSD, C&D's readers 
can self-test their progress by 
using the multiple choice 
question (MCQ) paper to be 



inserted in the August 10 issue, 
which will cover this week's 
modules, together with those in 
the July 6 issue. In other words: 
« Malaria (20) 
® Headaches (21) 
• Drugs in sport (22) 
® Needle exchange (23) 



A faxback service for these 
modules and associated MCQs 
operates on 0891 444791 
(premium rates apply). A 
telephone marking service offers 
independent verification of 
results - details are given on the 
monthly MCQ papers. 



C&D in association with 
^ o$wwn (Amen ° MSD 
Consumer Pharmaceuticals 



VIII 



CHEMIST & DRUGGIST 20 JULY 1996 



See what the 






market leader 





can do for you 



Complete" is the market leader in the fastest growing contact lens 
care segment. 1 

Complete' is exclusively available to opticians and pharmacists 
August national press campaign 



Reference I Soft lens cold chemical Independent Market Research 



COMPLETE 

There is only one solution 



Optometrists, like 
pharmacists, are 
m pallidal it lie if no lie ami 
taking on the 
management of minor 
c.-fr coiiiidittions. 
CfiristopSio Kerr, an 
optometrist in south 
London and consultant 
ilo y,lie 1 yecaire 
Information Service, 
explains how guidelines 
are being seu imgii io help., 
" ''--Acs, aii trends 
in contact lens wear 

As with pharmacists, the 
expertise of optomet- 
rists has perhaps been 
under used until re- 
cently. Poor communi- 
cation between optometrists and 
their medical colleagues has 
blighted the development of the 
Optometrie services in the t'K. 
But times are changing. 

In theory, the Opticians Act 
and subsequent legislation re- 
quires optometrists to refer all 
patients with abnormal condi- 
tions to their GP, without diagno- 
sis. The OP then eithei treats the 



patient or refers them for spe- 
cialist or emergency help. The 
optometrists' NHS Terms of Ser - 
vice further reinforce these 
responsibilities. It is, however, 
some years since these protocols 
were established and the quality 
of optometiic education and 
clinical ability have improved 
considerably over the years. 

It is now more widely accepted 
that the optometrist is probably 
best suited to treat a range of 
common ophthalmic conditions 
that do not require urgent refer- 
ral to hospital. These conditions 
demand a level of specialist 
knowledge and instruments that 
most GPs do not - nor wish to - 
possess. In the interests of con- 
venience to the patient and econ- 
omy to the health service, many 
'unofficial' arrangements have 
evolved locally over the years. 

Many optometrists have been 
safely and effectively treating a 
range of relatively minor and 
often chronic conditions which 
do not require acute manage- 
ment. They are now keen to 
advance their profession by 
expanding their range of practice 
in such areas. 

With this in mind, Lambeth, 
Southwark & Lewisham Health 
Authority drew up 'Referral 
guidelines for abnormal ocular 
conditions', after extensive con- 
sultation with optometrists and 



GPs. Copies were distributed to 
all optometrists contracted with 
the health authority. 

The guidelines list the main 
eye conditions likely to be seen 
in community practice and rate 
(hem according to how quickly 
they should be referred else- 
where or whether the opto- 
metrist could treat them. In gen- 
eral we would take those listed 
'urgent' as needing a specialist 
opinion that day; 'soon' as need- 
ing referral within a few days; 
and 'in turn' implying that a 'new 
patient' waiting time would be 
appropriate. We arrived at the 
range of conditions and referral 
priorities after extensive discus- 
sion and consensus. 

Some examples are given on 
page 91, in the hope that they 
may help pharmacists decide on 
the urgency with which patients 
should be referred. 

The document is for guidance 
only and does not in any way 
remove the rights of practition- 
ers to make individual decisions 
on individual cases. GPs were 
fully briefed to ensure that the 
introduction of the guidelines 
received a harmonious welcome. 

The cost of an ophthalmic out- 
patient visit in the Lambeth, 
Southwark and Lewisham area is 
£70 a consultation. Any means by 
which these expensive resources 
can be more effectively used is 



obviously in the interests of both 
purchasers and providers, and, 
most of all, the patients. The 
guidelines are such a stratagem 
and seek to give some consis- 
tency in referral policy, in line 
with the Patients' Charter 

The scheme is now being 
audited at the end of its first year. 
Opinions of both optometrists 
and doctors (GPs and ophthal- 
mologists) are now being sought 
as to its effectiveness in improv- 
ing inter-professional communi- 
cation and the more appropriate 
use of ophthalmic resources. The 
initiative has been enthusiasti- 
cally welcomed and supported 
by many concerned for the ulti- 
mate benefit of the professions 
and our service to patients. 

Changing contacts 

Contact lens research has led to 
an entirely new concept - the dis- 
posable lens. 

As modern lens materials have 
developed they have become 
more and mor e like body tissues 
or biocompatible, allowing the 
wearer's eye to breathe naturally 
beneath the lens. These delicate 
materials are so well accepted by 
the body that they eventually 
wear and become contaminated 
by cell products and, like the tis- 
sues themselves, need regular 
replacement. The contact lens 
industry thus faced a problem: as 



10 



CHEMIST k DRUGGIST 20 JULY 1996 



EYE CARE 



Some examples 
of the guidelines 

Urgent referral 

Acute glaucoma 
Chemical injuries 
Penetrating injuries 
Retinal breaks and tears 
Retinal detachment 
Sight-threatening keratitis 
Suspected temporal arteritis 
Uveitis 

Soon 

Scleritis 

Diabetic retinopathy 
In turn 

Ectropion (eversion of the eyelid 
margins) 

Entropion (inversion of the 
eyelid margins) 
Hayfever conjunctivitis in 
children 

Persistent blepharitis or 
conjunctivitis 
Severe dry eye 

Optometrist managed 

Chronic blepharitis 
Chronic dry eye 

Contact lens problems not invol- 
ving serious corneal infection 
Hayfever and allergic 
conjunctivitis in adults 
Sub-conjunctival haemorrhage 
with normal blood pressure 
Superficial foreign bodies and 
ingrowing lashes 



contact lenses became more and 
more perfect they lasted for 
shorter' and shorter periods! 

However, the development of 
sophisticated moulding technol- 
ogy has reduced the costs of con- 
tact lenses and made disposable 
or frequent replacement lenses a 
practical proposition. By fre- 
quently changing their lenses, 
wearers can avoid many of the 
complications sometimes associ- 
ated with contact lens use such 
as infections and allergic reac- 
tions. Disposable lenses are of 
varying types which are dis- 
carded after one day, one week, 
two weeks or one month. 

Success with all types of 
lenses pr obably depends mostly 
on the choice of practitioner, and 
price is rrot always the best 
guide. Anyone thinking of trying 
contact lenses should ask friends 
who wear lenses or their GP for 
advice in selecting a competent 
and conscientious practitioner 
who will give ongoing care. 

Fees are usually fairly low for 
disposables; about £30 should 
cover initial examination and fit- 
ting, tuition, supply of die first 
lenses and follow-up checks. 
When t he practitioner is satisfied 
that the lenses arc a success, the 
client registers with the practice 
and receives further supplies of 
lenses for the next three or six 
months. Monthly payments of 
around £15-20 ensure a constant 
supply. This fee should include 



lens warranty or insurance, as 
well as aftercare at regular inter- 
vals, typically every six months. 
These aftercare visits are vital. 

Disposable contact lenses, if 
properly maintained, have the 
best safety record of any contact, 
lenses yet developed Studies 
have shown that they are about 
four times safer than conven- 
tional lenses in terms of compli- 
cation rates. People who discard 
their lenses daily need no lens 
care solutions at. all. Those who 
change their lenses less often 
should still clean them every 
night and store them in a disin- 
fecting solution. But there is no 
need for other time-consuming 
cleaning routines such as protein 
removal. 

The contact lens practitioner 
will recommend the most suit- 
able solutions for' the lens mater- 
ial prescribed. These will lie 
products designed for soft rather 
than gas permeable lenses. The 
solutions must not be changed 
without consulting the practi- 
tioner. As well as the widely-pub- 
licised risks of using products for 
gas permeable lenses with soft 
lenses, some soft lens materials 
must be used only with specified 
solutions. 

( Irdinary soft lenses have an 
average lifespan of one to one 
and a half year s and cost about 
£150. ( )vei this tune, frequent 
replacement lenses usually work 
out less expensive because the 



higher cost of the lenses is bal- 
anced by the reduced cost of 
solutions. 

Disposables also give specta- 
cle wearers a chance to try con- 
tact lenses cheaply for the first 
time. No wonder eye care practi- 
tioners are encouraging their 
patients to throw away then- 
lenses! 

National Eye 
Week 1996 

This year's National Eye Week 
will be September 23-29. Once 
again the Eyecare Information 
Service will create 
opportunities for those who 
wish to capitalise on the central 
campaign. 

The organisers say the week 
will generate plenty of media 
interest, so why not organise 
your own in-store promotion, 
providing customers with 
information on eye care and 
optical products, or featuring 
Eye Week in a special window 
display? Many manufacturers 
will be supporting the event and 
may be offering promotions or 
discounts. 

The EIS can supply leaflets on 
a range of subjects. Tel: 0171 
357 7730. 

This year the focus of Eye 
Week will be on image and 
fashion. 




NEW H ffl 
ERADICATES SCABIES/ CRAB LICE t H 

MAKE A DIFFERENCE, RECOMMEND WMSM 



Liquid and cream shampoo, with malatflion 




STAFFORD MILLER 



DO3070 MAY 1996 



Legal category: P Product licence holder: Ultra Chemical, Tubiton House, Oldham 0L1 3HS. Quellada is a registered trade mark. Further information is available from the distributor: 

Stafford-Miller Ltd, Broadwater Road, Welwyn Garden City, Herts. AL7 3SP. 

CHEMIST & DRUGGIST 20 JULY 1 996 



91 



EYE CARE 



Keeping in contact 

The increase in professional only' contact lews care products is likely to be of benefit to the pharmacist. 
Adrienne de Mont looks at changing trends and the products which have evolved to meet them 



■ l is vital for pharmacies to 
I offer a full range of products 
I if they wish to maximise their 
I contact lens care business, 
I says Allergan. Customers can 
then buy everything they need 
from the same place. 

"It is also important that phar- 
macies continue to make lens 
care products prominently visi- 
ble and accessible to customers," 
says Amanda Byrne, senior prod- 
uct manager. 

The total contact lens care 
market is worth about ii 118 mil- 
lion and is growing by 10 per cent 
year on year. The optical sector is 
increasing its share, estimated at 
57 per cent ( up from 53 per cent 
last year), while pharmacies are 
declining slightly with 33 per 
cent (from 37 per cent). Grocers 
account for about 10 per cent. A 
rapid initial growth in this sector 
has stabilised at about 1 per cent 
year on year. 

Allergan says that the increase 
in 'professional only' products is 
likely to help pharmacies. The 
company's latest disinfecting 



products - Complete and Total 
Care - are available only through 
pharmacies and opticians. 

According to Allergan, the seg- 
ments are as follows: 

• soft lens disinfection 52 per 
cent (oxidative led by Oxysept, 
soft lens cold chemical led by 
Complete) 

• surfactants 1 1 per cent (led by 
LC-65) 

• general lens care 10 per cent 
(led by Total ) 

• salines 12 percent (led by Ciba 
Vision) 

• protein removers 7 per cent 
(led by Ultrazyme/Hydrocare) 

• wetting drops 1 per cent (led 
by Lensfresh). 

Peroxide systems dominate 
the pharmacy market, but there 
is a growing demand for one-bot- 
tle systems for soft lens wearers. 
These systems are by far the 
fastest-growing segment, with a 
70 per cent year on year growth. 
They have had a big impact in 
opticians but have yet to realise 
their full potential in pharmacies. 

"One-bottle systems now meet 



GOLDEN EYE' 

OINTMENT (0 1 5% w/w dibromopropamidine isethionate BP) I p I 
DROPS (0 1 % w/w propamidine isethionate) l_E_l 

"A sight for sore eyes" 

New formulation as an ointment and new eye drops 
Treats conjunctivitis, blepharitis and minor eye infections 
<M> 50% on cost profit plus w/s discount 
: Pharmacy Only guaranteed 
Available from your wholesaler 





^'ifSffLDEN EYE * 



lOmi 





Typhaim Limited 14, Parkstone Road, Poole Dorset BH5 2PG 
Telephone (01202)666626 Fax (0t202)666909 




a real need by lens wearers for 
simple and convenient lens 
care," says Ms Byrne. "Our Com- 
plete solution has seen rapid 
growth in pharmacy and has 
been instrumental in increasing 
the Allergan leadership position, 
which now stands at 51 per cent 
of the market. By stocking these 
simpler to use systems, pharma- 
cies can help to expand their 
business opportunities." 

The company is supporting the 
Association of Contact Lens Man- 
ufacturers in its bid to swell the 
ranks of lens wearers. Only about 
4 per cent of the UK population 
(2.5 million people) wear lenses, 
but the market is gr owing due to 
competitively-priced lenses, easy 
to use care systems and 
increased advertising. It is hoped 
the number of wearers could 
reach similar levels to the IIS, 
which is around 15 per cent. 

Trends in contact lens use 
obviously impact on the lens care 



market. Soft lenses are showing 
strong growth and disposables 
have doubled their market share 
in the past 12 months. Hard and 
rigid gas permeable lenses are 
declining in popularity. 

The latest Target Group Index 
Data shows that contact lens 
wearers are predominantly 
females aged 15-44 years. They 
are most likely to be ABC 1 and in 
full-time employment. There is a 
strong regional bias towards Lon- 
don and the South, although all 
regions are expanding. 

Consumer profiles have found 
that contact lens wearers tend to 
be outgoing, experimental, ad- 
venturous and career-orientated. 
The average user fits into one of 
two groups: urban venturers who 
are young adults with a high dis- 
posable income living in major 
cities, and affluent achievers 
who are high income families liv- 
ing in the suburbs and who own 
two or more cars, eat out regu- 




Easier to use systems have helped grow the contact lens care market 

CHEMIST & DRUGGIST 20 JULY 1996 



EYE CARE 



Read the market 

The OTC reading glasses market has changed since its introduction in 1989. But 
rather than stocking large numbers of designs in all the powers, the advice is to 
have a selection of good designs in a range of about six powers 



Lil ly, go to the theatre and follow 
investments closely. The former 
lend to lie (luiuilimi and Inde- 
pendent leaders, while the latter 
opt tor The Times, Financial 
Times and The Daily Telegraph. 
• Revive, Allergan's new comfort 
drops for soft lens wearers, is 
hem" supported by lull-colour 
advertisements m The Times, 
Evening Standard and the Daily 
Mail. The preservative-free for- 
mula is based on carboxymethyl- 
cellulose. A recent Gallup survey 
reported that a thud o1 people 
who give up wearing lenses each 
year do so because of comfort 
problems. 

Another new product from 
AUergan is Lens Plus Purite saline, 
a rinsing solution for soft lenses. 
The company says its telesales ini- 
tiatives have encouraged bettei 
merchandising and sell-selection. 
This month's offer is a mixed case 
of Oxysepl and Complete, with 
POS material. Complete is being 
supported by a S150,000 press 
campaign in August . 

Educational mater ial, including 
the guide 'You and your contact 
lenses', is available to pharmacy 
staff to help them understand the 
lens care products available 

Rhone- 
Poulenc 
Rorer has 
produced an 
eye care 
counselling 
pack, which 
includes 
consumer 
leaflets and 
a poster 



Avoid weird styles and do 
not be tempted to stock 
too many strengths of 
reading glasses, com- 
ments Direct Percep- 
tion's Peter Philips. 

Some frame designs will never 
sell at any price, he says, as the 
over-50s are unlikely to be happy 
with anything too startling. 

"We are selling to a more 
mature inai kel and the designs 
should be to their taste," he says 
"Unfortunately, there are suppli- 
ers with no optical background 
who seem to import whatevei 
they are offered providing the 
price is right. That is why we see 
so many weird-shaped frames 
that might suit the US oi the Far 
East but not the I IK. 

"Some designs sell better than 
others simply because they are 



specifically designed for the UK 
market. ( )ur search starts with an 
analysis of optical sales arrd, with 
t he help i if our panel i >f i >| it lcians, 
we plan the shape and colour 
very carefully on the basis of 
these findings." 

The better the designs, the 
more facial types they fit. And the 
smaller the stockholding, the 
greatei the profitability from the 
capital involved. 

"No one can display 50 differ- 
ent designs in all the powers. 
This only produces confusion 
and irritation for stockist and 
customer alike," continues Mr 
Philips. A range of six powers is 
enough. Ranges with nine pow- 
ers mean a 50 per cent larger 
stockholding for the same sales 

"What you need is a selection 
from some good designs, well 
made frames and lenses, in a well 
thought-out range. You need lull 
frames, half frames, metal and 
plastic, economy ones and 
smarter designs. 

"Regularity of supply is also 
important Do not get palmed ofl 
with inferior substitutes that hap- 
pen to be left on your suppliers' 
shelves." 

The ( )T( ' reading glasses mai 
kel has changed considerably 
since il began in IMS!). Many opto- 
metrists offer budget ranges of 
spectacles, after being motivated 
by NHS changes arrd the intro 
duction o1 readymades. This has 
shown up some of the expensive 
ranges as overpriced and has 
damaged then sales, says Mr 
Philips 

He calculates that the iead\ 

made market could be worth 
about £53 million, based on an 
estimate of 22 million people 
aged 45 years and over. Although 
not everyone uses readymades, 



others make multiple purchases 
at an average price of So' a pair. 
About 6 per cent of sales go 
through non-optical outlets. 

Eyecare Products estimates 
that the self-selection reading 
glasses market is nearer S22m. 
About one-third of sales are 
Boots own-label, one-third goes 
through other pharmacies and 
the remainder through supermar- 
kets, department stores and 
other independent outlets, in- 
chiding opticians 

There are about 24.5m people 
in the UK with presbyopia, the 
company says. ( )nce someone 
has started using reading glasses, 
he or she will change them for a 
stronger magnification every two 
to three years. So the market is 
growing rapidly with the ageing 
population. 

In Japan and the US - the 
world's most developed self- 
selection readers markets - it is 
not uncommon for consumers to 
have six or more pairs in various 
locations (home, office, car, etc), 
so they are never' far away from 
their glasses. 

Consumer buying patterns are 
spin between considered pur- 
chases and emergency/impulse 
buys which are needed when the 
usual, often prescription, glasses 
have been left behind. 

The latter often triggers further 
purchases as consumer satisfac- 
tion w ith self-selection readers is 
high, particularly as they start at 
prices well below the eye-test 
fee. 

"Independent phai mai ies are 
in a strong position to increase 
market share as consumers have 
the reassurance that the product 
is slocked in an ethical environ- 

Continued on P95 ► 






SAVE 

with Counterpart! 

you have retained all your counterpart modules the 
cost to you will be only £20 (+ VAT) per assistant! 
To re order all the modules at £15 (+VAT) and register one 
assistant at £20 (+VAT) still works out at only £35 (+VAT) 
per assistant. For four assistants the price reduces 
even further to £23.75 (+VAT) per 



J - J J J J 

1 

JULY 



DEADLINE NOW PAST! 



i—i r-i person! r- 1 



no 




The RPSGB deadline of July 1, by which all pharmacies in 
England, Scotland and Wales should have registered their counter 
assistants for an accredited training course, has now passed! 

If you have not already complied with the RPSGB requirements 
don't worry...there's still time. BUT YOU MUST HURRY! 



Register your staff now 



with the Chemist & Druggist Cambridge 
Counterpart Pharmacy Assistant Development Programme - the most 
cost-effective course available to Chemist & Druggist subscribers! 

# Cambridge Counterpart has been accredited by the College of 
Pharmacy Practice as satisfying the RPSGB's requirements. 

# Counterpart has been generously co-sponsored by Whitehall 
Laboratories for the benefit of Chemist & Druggist subscribers. 

# Since the course began in July 1995, subscribers will have 
received a total of 13 Counterpart modules. 

# The training modules are packs designed to be shared by four 
assistants, but include separate questionnaires and case studies 
for each individual. An associated Pharmacist's Briefing comes 
with each module. 

# To qualify for accreditation, assistants must not only follow the 
course set out in the modules but also answer the questionnaires, 
participate in the case studies and have their questionnaires 
independently mar ked thr ough C&D's unique telephone marking 
system. 



Sign up now! 



Here's what you do... 



1. If your assistants are already following Counterpart 
and are registered for telephone marking. ..continue 
with the course. Once it is completed, you will receive 
the results and documentation for CPP certification for a 
payment of £8.81 including VAT. 

2. If your assistants are following Counterpart, but are 
not yet registered for telephone marking... use the 

form below to register today! 

When your assistants receive their personal identity 
numbers (PINs), they should enter their multiple choice 
questionnaire responses up to date, then follow the 
course to the end. CPP certification will be available as 
above for £23.50 including VAT. 

3. If your assistants are not yet following 
Counterpart.. .use the form below now to register them 
today. If you have retained the free modules, start your 
assistants on the course at once and mark the 
questionnaires as soon as PINs are received. 

If you do not still have the free modules available, use 
the order form to obtain complete packs of the full 
course (training modules, questionnaires and 
Pharmacist's Briefings) for just £17.63, including VAT. 
Remember, each pack will cover four assistants! 

PIN registration and CPP certification fees are still 
payable as in section 2 above. Subscribers who have 
mislaid just one or two modules only should contact 
Tracy Matthews on 0181 747 8797 



Remember: if your counter assistants have not already completed an approved course or are not 
currently following an accredited course, they may no longer serve medicines to the public! 



Priority Order Form 



YES! My counter assistants are following 
Counterpart but are not registered to use the 
interactive telephone marking system. Please 
register them now @ £23.50 each including VAT. 

Name 

Name 

Name 

Name 

Name 

Name 

Total 



@£23.50 = subtotal £ 



YES! I subscribe to C&D at the pharmacy address 
below but need ( ) complete sets of all 
Counterpart modules to enable my assistants to 
complete the course. (Remember to register each 
assistant). 

Please send me ( ) complete sets of modules 
1 -1 3 at the special price of just £1 7.63 inc VAT 

If you do not already subscribe to C&D, or your 
subscription has lapsed, your cheque must include 
an additional £115 for the full annual subscription. 

Sub total £ 

Total payable £ 



Method of payment: □ I enclose a cheque 
payable to Chemist & Druggist 

Pharmacy 

Pharmacist 

Address 



Post code 



Tel 



Fax 



Post now in an envelope (no stamp required) with 
payment to Sue Cheeseman, Pharmacy Group Special 
Projects, Miller Freeman Professional Ltd, Chemist & 
Druggist, FREEP0ST, Sovereign Way, Tonbridge, TN9 1YZ. 



94 



CHEMIST & DRUGGIST 20 JULY 1996 



EYE CARE 



In the public eye 

Customers looking for eye care products usually visit the pharmacy first. 
Research shows that as 86 per cent of products are sold here, good 
merchandising is essential as customers are more aware of their needs 




l-Doc: supported by consumer advertising this summer 



< Continued from P93 

ment and can seek assistance 
from the staff it necessary," 
says Eyecare Products, whose 
25 per cent market share 
includes the Readi Read, Foster 
Grant and Magnivision brands. 
I lisplay is the key factor in good 
sell-through. 

What to choose 

• Eyecare Products' 29 styles 
conform to British Standards 
(European standards pending) 
and carry a 12-month guarantee. 
All lenses are aspheric, so they 
aie thinnei and flatlet than con- 
ventional spherical lenses. A 
range of Sun-readers pr< ivides 1 A' 
protection. 

The company's service in- 
cludes next day delivery on 
repeat orders, low minimum 
repeal orders (three pans 
mixed), opening deals, free dis- 
play stands to suit all si/.es of 
outlet, and a lelesales service or 

regular merchandising for largei 
outlets All displays include an 
ophthalmically-appn >ved sight- 
tesl inn chart f< ir selecting I he <•< >r- 
recl strength. 

Future plans for this year 
include public relations, further 
stand developments, promotional 

oilers to the retailei and con 

sumer, and a constanl updating of 

styles. 

• Direct Perception's prices 
range from £2.98 to £10.98, w hich 
Mr Philips believes should cover 
the needs of everyone, from the 
person who wants a basic pan to 
the one who w ishes to enhance 
his appearance with a better 
design. Stockists can experiment 
with new mi idels, which I he c< >m- 
pany is quite happy to exchange if 
necessary. 

"This way, a stockist of a bud- 
get range may gradually test the 
market out with better models," 
says Mr Philips. Several promo- 
tions will i mi over the next few 
mi ml lis. 




Modern lifestyles are good for 
the eye care market. Pollution, 
air conditioning and staring at 
computer screens all put strain 
on i he eyes. 

Research by < )rookes Health- 
care shows that the number of 
people suffering from minor eye 
complaints is on the increase, 
with the result that the < »T< ' eye 
care market is growing steadily 
and is now worth .S 18 million. 
About ten million people - over 
one-fifth of adults - use < iptrex 
and the brand accounts for 71 
per cent of the market. 

The introduction of < Iptrex 
Dry Eye Therapy eye drops in 
April was an attempt to expand 
the market as a whole and to 
offer an < iptrex product in an 
area with no other promoted 
brands A survey in 1994 found 
i hat ( ivei half i he 3.3 millii in dry 
eye sufferers were unaware that 
remedies existed. Promotion will 
be targeted both at these people 
and current users of dry eye 
I real inents. 

This year sees the highest-ever 
promotional spend on the< >ptrex 
brand Explains product man- 
ager Pisa Miller: "By educating 
the consumer and increasing 

awareness of eye care through 
both educat ional i >ublic relatii ms 
and high-profile advertising, we 
are Stimulating demand for eye 
care products and making the 
category more accessible to the 
ci msumer " 

Research shows that 86 per 
cent of eye care products are 




bought m pharmacies, so 
Crookes Healthcare believes that 

g I merchandising is essential 

as customers become more 
aware of their eye care needs and 
the role of ' >T< ' medicatii m 
ii h i eases in general. 

New display units and shell' 
managers form pari of this year's 
&3m support programme. A two- 
tiei countei unit provides space 
for 12 packs of the dry eye drops, 
as well as a new customei infor- 
mation leaflet A flexible modu- 
lar shelf management system for 
use behind the counter can 
house all ( iptrex products, 
including Hayfever Allergy. A 
new shell manager for use in the 
< 1S1> atea houses the lotion and 
eye masks, 

Rhone-Poulenc Rorer com- 
ments that over the past year 
Brolene's share has lumped to 22 
per cent of the ,S7 (ini eye c are 
market through pharmacy 
(excluding Boots) and accounts 
for 90 per cent of the anti-infec- 
I ive segment 

OTC marketing manager 
kevan (iill explains: "Consumers 
are very reluctant to self-diag- 
nose where eye problems are 
concerned, and need the reassui 
ance and recommendation of 
then local community pharma- 
cist who can offer them a per- 
s< dial service." 

The c< impany has produced an 
eye care counselling pack for 
pharmacists and their assistants. 
It contains leaflets OI1 the lour 



most common complaints 
allergic seasonal conjunctivitis, 
infective conjunctivitis, blephar- 
itis and styes - to pass on to cus- 
tomers, after consultation. 

An illustrated poster for use 
in the pharmacy helps identify 
eye problems and gives guidance 
on their treatment. Both are 
available tree from the com- 
pany's representatives. 

• Golden Eye drops and oint- 
ment are being advertised 
nationally on radio, and 
Typharm is sponsoring pollen 
count bulletins. Advertising is 
appealing in the Daily Mail 
health pages and women's maga- 
zines, as well as some medical 
journals. A new range of POS 
materials and leaflets is avail- 
able from the company. There 
are special offers from whole- 
salers throughout the summer 
and a compel if ion for pharmacy 
staff, with prizes of the '( iolden- 
eye' James Bond video, runs 
until the end i if August. 

• A public relations campaign is 
in progress for new l-Doc preser- 
vative-free eye lotion. There are 
advertorials in the women's 
press and sampling through the 
national Sunday supplements 
ami women's interest piess. 
Advertising is appearing in the 
.luly and August issues of 
Options, Mm ir < 'laire and Zcsl. 
Containing distilled witch hazel, 
l-Doc is packaged in single dose 
ampoules w hich contain enough 
lotion lo bathe both eyes. 




rHKMIST*l)RI(;(ilST?n.ll)LY19R6 



BUSINESS NEWS 




o RPM - no pharmacy' 



On another positive note, 65 
per cent intend to expand their 
businesses by adopting new ser- 
vices, such as consultancies 'in 
situ'. 

The increasing power of gen- 
eral practitioner fundholders 
brought mixed reactions. While 



Ninety-one per cent of pharma- 
cists believe their businesses 
would be threatened by the 
removal of Resale Price Mainte- 
nance, according to a Glaxo Well- 
come survey. Eighty-eight per 
cent also feel threatened by 
changes in Government remu- 
neration I lispensing 
doctors, meanwhile, 
are regarded as pot- 
entially harmful by 
81 per cent of the 
pharmacists. Slightly 
lower down the 
scale of threats are 
wholesaler-owned 
outlets, which alarm 
75 per cent . 

However, most of 
the pharmacists are 
keen to fight on. Sixty 
per cent say they are Ian Millar, a community pharmacist at Seres 
not seriously consid- Road Pharmacy in Glasgow, won a Toshiba 
ering getting out of Pentium-powered laptop for taking part in Glaxo 
retail pharmacy, 24 Wellcome's questionnaire. He is flanked, from 
per cent appear to lie the left, by Doug McLean, account manager at 
giving the notion Glaxo; Rose-Marie Parr, director of the Scottish 
some thought, and 14 Centre For Pharmacy Postgraduate Education; 
per cent are seriously and Maureen Devlin, Glaxo's customer manager 
considering quitting, (pharmacy) 




48 per cent of the pharmacists 
say the trend is a threat, 22 per 
cent see it as an opportunity. 

Forty per cent believe patient 
pack dispensing is an opportu- 
nity for their business, as 
opposed to 20 per cent who see it 
as a threat. 

The development of primary 
care teams is considered good by 
60 per cent of the pharmacists, 
while 48 per cent see the nurse 
prescribing pilot as an opportu- 
nity for their businesses. 

Glaxo sent out more than 8,000 
questionnaires to community 
pharmacists around the UK in 
April. The company says it will 
use the information as a base to 
build a better relationship with 
them. 

The questions ranged from the 
respondent's purchasing respon- 
sibility to general attitudes 
towards key issues. Glaxo says 
the response was excellent. 
Those who completed the ques- 
tionnaire were eligible to win a 
laptop computer, software and 
modem worth £3,000. Ian Millar, 
of Glasgow was the winner. 



Co-op Health Care 
acquires more stores 



Co-op Health Care, the pharmacy 
chain operated by United Nor- 
west Co-op, has acquired five 
pharmacies in the North Mid- 
lands and north west of England. 

The chain, which now has 49 
stores, plans to acquire at least 
another six by the end of the year 
and will again be looking in these 
two regions. 

A spokesman for Co-op Health 
Care says the latest acquisitions 
are in line with its plans to 
expand in the North West. More 
stores also improve the chain's 
buying power, he adds. 



The c hain has 
been strengthen- 
ing its manage- 
ment team over 
the past year to 
cope with its 
expansion. New- 
comers include 
a professional 
d e v e 1 o p m e n t 
manager to help with recruit- 
ment and to maintain profes- 
sional standards, and an integra- 
tion manager, whose brief is to 
aid new branches in assimilating 
into the organisation. 




Geoff Flint, right, controller of Co- 
op Health Care, and Philip 
Broadhurst seal the Co-op's 
acquisition of Mr Broadhurst's 
pharmacy, Stoke-on-Trent-based 
JHMcEllin 



Astra fights Losec copies 

Astra, the Swedish 
pharmaceuticals group, has 
lodged a complaint with the 
European Commission against 
Portugal for approving 13 pirate' 
copies of its anti-ulcer agent, 
Losec, according to the Financial 
Times. Astra estimates that it is 
losing S12 million annually to 
Losec imitations. 

Proteus reduces losses 

Revenues earned from licensing 
agreements and a cost-cutting 
programme helped Proteus 
International, the Macclesfield- 
based biotechnology company, to 
reduce its pre-tax losses by £2.5 
million to £5.4m for the year to 
March 31. 

Alberto-Culver expands 

Hair care and toiletries 
manufacturer Alberto-Culver is 
investing £3.15 million in a new 
50,000ft 2 manufacturing site at its 
base on the Swansea Enterprise 
Park in South Wales. The 
expansion will create 100 new 
jobs. 

Sun worshippers 

Balmy weather in June brought 
very good sales of sun 
preparations in pharmacies and 
department stores, while demand 
fell for cough and cold products, 
according to the British Retail 
Consortium. The weather also 
lifted sales of hay fever remedies. 
Demand was mixed for 
cosmetics. 

Therapeutic flotation 

Therapeutic Antibodies, which 
produces polyclonal antibodies 
to treat diseases, has fallen prey 
to the rapid decline of 
biotechnology shares. The 
company expects a placing price 
of 525p per share, valuing it at 
£112 million, when it is floated on 
the Stock Exchange next week. 
The company had originally been 
hoping to price its shares at 700- 
800p. 



Chiro founder reaps reward 



Bearish market bites into Alizyme flotation 



Chris Evans, founder of Chiro- 
science, the biotechnology com- 
pany, has turned 816,000 share 
options into shares. 

Mr Evans, now a non-executive 
director of the company, bought 
600,000 shares at 25p and 216,000 
at 16.67p. Having paid £186,007 
for them all, Mr Evans would 
make a profit of more than S2.6 
million if he sold them at their 
market price of 346p [share price 
quoted on July 12). However, he is 
said lo have no immediate plans 
to sell. 



Alizyme, a biopharmaceutical 
company based in Cambridge, 
expec ts a relatively poor recep- 
tion when it is floated this week 
because of the current bear mar- 
ket for biotechnology shares. 

It expects to raise about £4.5 
million net when it joins the 
Alternative Investment Market. 
By contrast, three weeks ago, 
Alizyme said it was expecting to 
raise between £12- 13m through 
the flotation. 

This week's placing price will 



be 60p, valuing the company at 
about £10.4m, although it had 
originally been hoped to place 
shares at 150p. 

Alizyme will issue 8.33 million 
shares that represent 48 per cent 
of the enlarged shar e capital. 

It will use the money raised to 
fund product development The 
company is developing drugs to 
combat obesity and gastro- 
intestinal disorders. Such drugs 
are developed from a late stage 
of their research and supervised 



through pre-c linical testing to the 
end of Phase II trials. The prod- 
ucts are then licensed out to 
other companies for late stage 
trials, commercial manufacturer 
and marketing. 

The company is collaborating 
with Oxford Molecular and the 
Institute of Food Research to 
develop lipase inhibitors for use 
in obesity and atherosclerosis, 
and with BTG on drugs for 
inflammatory bowel disease, 
diarrhoea and flatulence. 



38 



HHRMIST & DRITfifilST 20 JULY 19 



Classified 



Appointments £25P.S.C.C. + VAT minimum 3x1 
General Classified 123 P.S.C.C. + VAT minimum 3x2 
Box Numbers £ 1 2.00 extra. Available on request. 
Copy date 4pm Tuesday prior to Saturday publication. 
Cancellation deadline 1 0am Friday; one week prior to insertion date 
All cancellations must be in writing 

Contact Lucy Reynolds Chemist and Druggist (Classified) 



Miller Freeman PLC, Sovereign Way, Tonbridge, Kent TN9 IRW 
Tel: 01732 377222 Internet: http://www.dotpharmacy.com/ 
ALL MAJOR CREDIT CARDS ACCEPTED 



VISA 



Nr Cross Keys, Gwent 

EnchusiasiK Pharmacist required to manage 

pleasant village pharmacy \ xccllcnt 
supporting stafi Pleasant disposition and a 
liking tor pjucm contact essential- Hours 
and salary negotiable 
rdephone Alan Peterson on 
01495 244227 (daytime) or 
0149S 244226 (evenings). 



Full & Part-time 
Pharmacist/ 
Managers 

Required 
Bournemouth Area 
Competitive salary, 
holidays & excellent 
team of staff, 
/t/'/'/t/ Mrs Cough 
Tel: 01202 749397 
01202 523481 



Multi Pharmacy chain require 
evening locnms to work in t ho 

following stores. 
Rygate Surrey 01737 244132 

(4pm-10pm) 
Hadleigh, Essex 01702 555321 
Felixstow, Suffolk 01394 276297 
(until Xpm) 
Upper Norwood, S. London 
01X1 7717639 
(until Hpm) 



DISPENSING TECHNICIAN 

NORTH LONDON 
(ISLINGTON N1) 

Dispensing/Medical Counter 
Assistant required lull time (part 
time considered). Newly extended 
and refitted pharmacy. 

References required 

Please phone The Manager 
0171-226 3645 



APPOINTMENTS 



Superintendent Pharmacist 

required immediately for high 

street pharmacy. 
Please contact Mr O. Dede 
on 0181 692 5807 9am-7pm 
or Miss McCarthy on 
0181 692 3725 9am-7pm 



DISPENSING ASSISTANT 

Burghfield Common, nr. Reading 

Experienced dispensing assistant 

required part time for a busy 
community pharmacy Good rate of 
pay. 

Phone Mrs Thomas on 01734 
831145 (daytime) 
or 01734 845740 (eves & w/ends) 



SUNDERLAND 

Pharmacist manager required for 
easily run branch of small friendly 
group. No paperwork. Very few 
Saturdays. 

Apply to P. Henderson, 95 Park 
View, Whitley Bay, TVne and 
Wear NK26 3RJ or telephone 
0191 252 0253 



LEWISHAM SEI3 

Enthusiastic Pharmacist 
Manager required fur an easily 
run pharmacy Recently 
qualified considered 
Please contact: H.C. Patel 
0171 476 0243 (daytimel 
0181 464 4812 (evening) 



LOCUMS 



LONDON N7 
LOCUM REQUIRED 

from 5th August for 6 
weeks. 
Contact Kirit on 
0171 249 2441 (day) 
0181 881 3977 (eve) 



LIVERPOOL 

Manager required for easily run 
branch pharmacy, good supporting 
staff, attractive salary with profit 
sharing incentive. Newly 
registered considered. 

Apply P. Lappin 0151 236 0618, 
0151 722 3926 (eve). 



Friendly family pharmacy 
group require a 
PHARMACIST/MANAGER 
for village pharmacy near 
Eastbourne. Interested 9 
Phone Paul Houston 
01323 411047 or 647420 
(eves) 



LOCUMS 



RROVINCIA 
LOCUM 

We have over 5,000 pharmacists 
registered PLUS experience of 
handling over 250,000 booking 
NATIONWIDE! 



' Provided by experienced staff. 
1 Locum bone-fides checked. 
' A mobile & motivated locum 



• Pharmacist staff to deal with 
technical issues. 
LEAVE THE WORRY TO 



PHARMACY 
SERVICES 

Plena eM 



Bvmitqlum 0121-233 0233 
NwcaitU 0191-2330506 
MmdutU 0161-766 4013 
SUffull 0114-2699 937 
Edbthwyk 0131-229 0900 
Cardiff 01222 549174 
London 01892 515963 
Exit&t 01392422244 



London SW4 

Regular lotum pharmacist required 

to cover late night dispensing 
in Clapham, for Thursdays & Fridays 
b-9pm. knowing Mediphase is 
desirable. Salary by negotiation. 
Telephone Dr. Gharib 
0171 622 3147 



SELF-EMPLOYED 
LOCUMS 

+ Are you familiar with 'self- 
assessment' rules starting from 
April 1996? 

* Qualified Accountant provides 
a full accountancy/tax service 
for reasonable rates. 

Tel: 0181 908 5006 



Seaton, Devon 

Locum required on a 
regular basis. Also for 
another local pharmacy. 
Telephone W. Gaine on 
(01297) 20414 or (01297) 
21739 



LOCUMS 

Urgently required in 
South Waits & Bristoi area 
• Competitive rates oi pay 

• Olll) DAYS & LONG TERM AVAILABLE 

Contact 

Capital Support Services 

Tel: 01222 540940 
Fax: 01222 54'M«5 



CHEMIST ADRI'MilST 20 JULY 1996 



57 



BUSINESS OPPORTUNITIES 



COMPUTER SYSTEMS 



BUCKINGHAM 

Run your own business without any capital investment. 
Unique opportunity has arisen for a Pharmacist with 
business acumen to operate this branch on a profit share 
basis. 

For further details contact H. Modi, Jardines (UK) Ltd. 
Telephone 01908 506828. 



BUSINESSES FOR DISPOSAL 



ALLIANCE VALUERS & 
STOCKTAKERS 

(01423) 508172 
S W WALES COLCHESTER 



Retirement sale of unopposed pharmacy in 
delightful coastal village. T/O FYE April 95 
£426,807. CP 27.4%. NHS items average 
3,460 per month Immaculately presented 
premises available on new lease or freehold 
with attractive four bed living accom if 
required Offers invited around £225,000 for 
GW/Fix plusSAV. 



Long established suburban pharmacy. T/O 
FYE April 95 £642,656. NHS items average 
5,500 per month. Prominent corner premises 
available on new lease at £5,000pa. An 
extremely profitable concern. Offers invited 
around £400,000 for GW/Fix plus SAV 
(approx £55.000) 



lOOKING IX) BUY OR SHI A PHAKMAC Y> ( ON I AC I US NOW. 




COMPUTER SYSTEMS 



% UNTIL THE END OF SEPTEMBER 
YOU CAN BUY 

'Simply the besf 

LABELLING & EPoS SYSTEMS 



PHONE TODAY FOR MORE DETAILS 



PARK SYSTEMS LTD. 

6 Vulcan St, Liverpool L3 7BG 
Fax: 0151-298 1689 

'Subject to Park's standard terms and conditions 



BUSIN 




A FREE Service for Chemist & Druggist Subscribers 



35, Dansac unique 2-55 ref 502-55. 
Trade less 20%+ VAT+ Postage - 
Paroven caps 250mg, Loron 520 
tabs, Cardura tabs 4mg. Tel: 01923 
825753. 

TRADE LESS 25%+VAT+POSTAGE - 

6 Pergonal 7587 inj+solvent (exp 
10/97), 10 DepLxol inj 40mg/2ml (exp 
2/98), 4 Fortral 30mg/ml inj (exp 
1 1/97), 1x5 5ml Suprefact S/C inj (exp 
11/97), 3 Deca-Durabolin 50mg/ml 
(exp 3/97), 2 Sustanon 250 1ml inj 
(exp 12/97) and many others. Tel: 
0181422 2563. 
TRADE LESS 20% + VAT + 
POSTAGE- Opsite 10cmxl2cm 
4630. Trade less 1 5%+ VAT+ Postage 

- Coloplast Assura 2471, Comfeel 
iOcmxlOcm 3213, Mepore 9x10cm. 
Tel: 0171 620 0429. 

TRADE LESS 30%+VAT+POSTAGE 

- 456 Loron 400mg caps, Farlutal 
lOOmg tabs, Provera 400mg Tabs, 



Danol 200mg caps, Calcitare vials, 
Duocal cans 2x400g, Desferal iiu 1 
box. Tel: 0181 672 6116. 

TRADE LESS 30%+VAT - 38 Dutonin 
200mg, 53 Cedocard Retard 400mg, 
90 Hydergine 1.5mg, 3 Lentaron 
Depot 250mg, 5 Inj Kemadrin. Tel: 
0181 904 4197. 

TRADE LESS 30%+VAT - 1 1x30x3118 
Hollister, 2x30 Hollister 7164. Tel: 
0171-730 1080. 

TRADE LESS 25%+VAT - 2x30 Neoral 
50mg (exp 7/97), 4x30 Neoral +vat 
(exp 9/97), trade less 40% - Norplant 
(exp 9/96). Tel: 01793 495499. 

TRADE LESS 20%+ VAT - 33 Celectol 
200mg, 28 Climesse 2mg, 100 Flur- 
biprofen 50mg, 84 Ketoprofen LOOmg, 
42 Foradil 12mcg, 28 Monocor lOmg, 
80 Volmax 4mg, plus others. Tel: 
01827 262488. 

TRADE LESS 40% - Suprefact spray, 
Cyproterone 50mg £20/56 tablets. Tel: 




Increase Profitability 
Enhance Customer Care 
Increase Staff Motivation j> - , 

Improve Communication m rVOjCSSlOtlM 

improve Efficiency I .j Dispensing Systems for 

Provide Profes^nTpractfce Image II Professional PhatWadStS 
Increase Flexibility II FOR DETAILS 

AND/OR A FREE DEMONSTRATION: 

Tel: 0161 9417011 

PACE BETA COMPUTERS, FREEPOST ALM 1610, ALTRINCHAM, WA14 1AR 



IBM computers are amongst the most highly 
respected in the industry . They have unequalled 
reliabilty, are manufactured in the UK and have a 
reputation second to none. It is only fitting they 
should run software of equal standing. That 
software is JRC. 



IBM & JRC, forward thinking , here for 
the future. 

Call John Richardson Computers 

(a division of Taylor Nelson AGB pic) 



ON FREEPHONE: 0500 947116 




*91% of Community 
Pharmacists have read four 
out of the last four issues 
of Chemist & Druggist. 

('source Martin Hamblin Pharmacist Readership Survey) 



01582 21760. 

TRADE LESS 30%+VAT - Celance 
0.25mg x 0.05mg, Dalacin 150nig, 
Axid 300nig, Sandimmun 25mg, Lam- 
ictal 50mg, Zydol SR, Cipramil 20mg, 
Becodisk 150, Berstec 200, Aerobec 
Forte. Tel: 01623 643801. 

TRADE LESS 30%+VAT - 300 Lopid 
300mg (exp 10/96), 100ml Bactrim 
Paed syrup (exp 9/96), 2x56 DMC 
90mg (exp 8/96), trade less 40%+vat, 
100 Kinidin duniles (exp 9/96). Tel: 
01438 312228. 

TRADE LESS 20% + VAT + 
POSTAGE - 6x30 Convatec Com- 
bihesive pouches 45mm S265, 4x10 
Stomahesive flange 45mm S241 
Tel: 01792 458883. 

TRADE LESS 30%+VAT - 15 Vagifem 
(exp 2/97), 56 Lederfen 450 (exp 
8/99), 50 Lodine 200mg ( exp 6/97), 56 
Ludiomil 25mg, 100 Tegretol retard 
400mg (exp 6/97), 3x28 Climagest 
(exp 1 1/96), 3x28 Climagest lgm (exp 
6/97), 30 Voltaren lOOmg (exp 3/97). 
Tel: 01 16-283 2140. 

TRADE LESS 30%+VAT - 1x250 Hex- 
opal forte dispensing pack (exp 7/00). 
Tel: 01667 462617. 

TRADE LESS 25%+VAT - 10x28 Nys- 



tan pessaries (exp 1/97), 10x150 
Atarax syrup (exp 5/00), 36x42 Para- 
max tabs (exp 11/98), 6x30 ManerLx 
(.exp 9/99). Tel: 01274 593274. 
TRADE LESS 60% + VAT - 7 Oxygen 
stands, unused, 5.5 inch, new price 
S16.16+vat. Tel: 0181-684 1352. 

FOR SALE 

QUALITY SHOPFITTINGS Less 
than three years old, four perfume 
cabinets, two counters, gondola, 
shelves, dispensary fittings, conti- 
nental drawers, light fittings, safe 
and Mediphase computer. Tel: 
01494 520685. 

MARTINDALE 29TH EDITION As 
new, hardly used £40. Tel: 0181-684 
1352. 

PARK SYSTEM SOFTWARE Version 
7, Packard Bell 486 Multimedia 8MB 
RAM, Star colour printer, complete 
system, ready to run £800. Tel: 01474 
352609. 

MINI LAB Oriental mini 2, complete 
system which prints up to 8x12, 100 
films a day, ideal for busy phar- 
macy, one year old Tel: 01703 
869820. 



CHEMIST & DRUGGIST 20 JULY 1996 



COMPUTER SYSTEMS 



PRODUCTS AND SERVICES 



+ CAMRx + 

FOCUSING ON THE FUTURE. 
PERSONAL AND VALUABLE 
SERVICE AT ALL TIMES 



Alchemist 3000 PMR 

dispensary system 
NEW VERSION !!!!!! 

Prophet 2000 EPOS 
Intelligent till system 
Transform your business 





All 

Net-Workable 



We use our 
engineers 



We deliver & 
install FREE 



Police Station 

'i>l ffl I 77 7\ f,7 



DISTRIBUTORS WANTED 



CLEARWAY INHALER is now established as the 
preferred way of inhaling steam and aromatics in the 
treatment of catarrh, sinusitis, coughs and colds. 
We now require distributors willing and able to 
promote and sell to community pharmacies. Please 
reply to Clearway Products Ltd., Kiln House, 
Station Road, Wisbech St. Mary, Cambs. PE13 
4RW or telephone 01945 410466 for further 
information. 



JOIN THE GROWING BAND 
of PEOPLE who INCREASE 
their PROFITS by £££££'s 



1. A vital invc 
base will p 



ridable negotiati 



2. Group 31 o ^jMj) adds pounds to 

3. Our negotiating skills, contacts and know 
how will bring you extra savings from 
numerous companies. 



COULD REVOLUTIONISE YOUR BUSINESS 

54/62 Silver Street, Whitwick, Leicestershire LE67 3ET 
TEL: 01530 510520 FAX: 01530 811590 



RING FOR DETAILS ON 
FREEPHONE 0800 526074 



COPY DEADLINE FOR THE 
27TH JULY IS TUESDAY 
23/07/96 - CALL 01732 377 222 



BUSINESSlink 



A FREE Service for Chemist & Druggist Subscribers 



EXCESS STOCK 



S25.00 + VAT + POSTAGE - 10 x 

Cusilyn eye drops 13.5m] (soil cro- 
moglycate 2%) exp 1/97. Tel: 01223 
568190. 

TRADE LESS 50% + VAT + 
POSTAGE - Coloplast - 1285 4x10, 
12705x50, 1200 2x30, 12507x5, Sur- 
gicare SI 00 2x5, S351 1x5, S240 
1x10, SI 1x4, Conveen S125 2x30, 
S120 1x10, S172 1x10, S236 1x10, 
S272 2x10, S313 1x10, Dansac 226- 
60 4x30, 226-40 1x30, 226-45 2x30. 
Tel: 01202 262486. 

TRADE LESS 50%+VAT - 63 Dol- 
matil 200mg (exp 10/96), 66 Neu- 
rontin lOOmg (exp 8/97). Tel: 01269 
822217. 

TRADE LESS 30%+VAT - 2x42 Val- 
trex tabs (exp 10/96), 3 boxes Corn- 
fell over dressing 20cm 2 Tel: 0171 



485 1251. 

TRADE+VAT - 190 Pentasa M/R 500mg 

(long expiry) Tel: 0121 477 0123. 
TRADE LESS 25%+VAT+POSTAGE - 

260 Megace tabs 40mg (exp 11/98), 
5x100 Hormonin tabs (exp 2/08), 
1x120 Alu-cap caps (exp 3/07) Tel: 
0181 651 6062 
TRADE LESS 50%+VAT - 4 boxes 
Predfoam enemas (exp 8/96 & 12/06), 
3x5Cytamen inj 1000mg(exp 11/96), 
3 Zofran inj 2mg/ml (exp 0/07), 60 
Loron 520 tabs (exp 1/98), 12x4ml 
Uromitexan inj (exp 11/98), 1 I)e-Nol 

labs (exp 11/98), 100 Parlodel lmg 

(exp 1 1/96) plus others. Tel: 0161 480 
6422 

TRADE LESS 50%+VAT - 10 vials 
Genotropin 16iu, Kabivial multidose 
(exp 10/96) guaranteed fridge stored, 
buyer to arrange colleciioti Tel 
01382 611227. 

TRADE LESS 25% + VAT - Duphalac 



dry sachet, Alrheunial caps, 
Alphoditl) (team, Kersanial labs, 
1000 Triludan OTC packs. Trade less 
20%+ VAT - Zofran 8mg. Tel: 0181 520 
5820. 

TRADE LESS 50%+VAT - 2x10 
Normegon 150iu (exp 10/06) Tel 
01227 457830. 

TRADE LESS 50%+VAT - Provera 
400mg, Nicotinic acid 50nig, Rocal- 
tro!0.5mcg, Importal Danazol lOOmg, 
Targocid 400mg, Cesamet lmg, 
Litarex Minodiab 2.5mg, Loniten 
5mg. Tel: 0181 874 1405. 

TRADE LESS 30%+VAT+POSTAGE 
1 Predfoam, 120 Anturan 200mg, 60 
Coracten lOmg, 80 Mexitil 50mg, 408 
Mexit.il 200mg,30 Provera 400mg, Tri- 
nordiol, .84 Gamanil. Tel: 01963 
25025!). 

TRADE LESS 25% + VAT+POSTAGE 



Cardene SR 45 x 56 (exp 10/96), Cor- 
win200mgx 186 (exp 11/97"), Retrovir 
250mg x 37 (exp 7/97). Tel: 0191 528 
4444. 

TRADE LESS 40%+VAT+P&P - 80 

Aspav (exp 12/96), 16 Coloplast 
a.ssuia uro bags 2550, 25 Voltarol 
50mg suppositories (exp 11/96), 32 
white Tenoretic (exp 2/97), 4x28 
Sinequan 25mg (exp 8/98), 2 packs 
Napratec (exp 11/96), 25 Adizem SR 
90mg (exp 11/96) and many others 
Tel: 01693 8:30261. 

TRADE LESS 30%+VAT - 6 Lentaron 
t.m depot 250mg (1 ampoule 
250mg/l ampoule of 2ml) in each 
box. Tel: Blackpool 301522. 

TRADE LESS 
30%+VAT+POSTAGE - Zinamide 
500mg, Dansac unique 2-55 ref 555- 
35, Dansac unique light 35 ref 255- 



EXCESS STOCK CAUTION 
Pharmacists are responsible for the quality, safety and efficacy of 
medicines they supply. In purchasing from sources other than 
manufacturers or licensed wholesalers, they must satisfy them- 
selves about product history, conditions of storage and so on. 



CHEMIST & DRUGGIST 20 JULY 1996 



PRODUCTS AND SERVICES 



medieltte pic 

Tel 0181 841 4144 Fax: 0181 841 H i ■% 

BRflun 




INDEPENDENT 2000 ENERGY CELLS 




BUY 50 mm CELLS GET 5 MINI CELLS FREE 
MEDIELITE=PROFIT PLUS 



The Power 
of Multiples . . . 
...the Privilege 
if Independence 

UK's fastest growing 
buying network of 800 

independent 

pharmacist 

* join us now * 



Wish to become a member? Nucare pic 

Please contact us Today. 447 Keruon Road 

Harrow 

Middlesex HA3 OXY 
Tel: 0181-732 2772 
Fax: 0181-732 2774 




CHEMIST & ^ ers ^ e mos ^ com P re ^ ens ^ ve selection of products 

TppTCT& services of in any Pharmaceutical Publication. 
VMmm. call Lucy on 01732 377222 



To pit your Products & Services in front of our unique readership 



Free entries in 
"Business Link" 
(maximum 30 
words) are 
restricted to 
community 
pharmacist 
subscribers to 
Chemist & 
Druggist. No trade 
advertisements will 
be permitted. 
Acceptance is at the 
discretion of the 
Publishers and 
depends upon space 
being available. 
Send proposed 
wording to 
"Business Link" 
using the form 
printed alongside. 



To: Business Link, CHEMIST & DRUGGIST, Miller Freeman House, 
Sovereign Way, Tonbridge, Kent TN9 1RW. 

PLEASE COMPLETE IN BLOCK CAPITALS 



Surname . . . 
First names . 



Address 



Postcode 

Personal RPSGB Registration number 

Telephone Number 

Proposed advertisement copy (maximum 30 words) 



100 



CHEMIST & DRUGGIST 20 JULY 1996 



SHOPFITTINGS 



SPECIALS 



5f|opriTfiNc; 

FROM LOW COST PERIMETER SHELVING TO 
UPMARKET PERFUMERY SHOWCASES TRADITIONAL 
OR CONTINENTAL DISPENSARIES 

CONTACT MARTIN BAGG FOR A COMPLETE 
SHOPFITTING SERVICE FOR THE PHARMACIST 

01392-216606 



WOODSTYLF 

Y Y SHOPFITTING AND DESIGN ■ 



SPECIALISTS IN RETAIL PHARMACY 
AND DISPENSARY SHOPFITTING 

APPROVED BY THE N.PA. 
CALL NOW FOR DETAILS 

Edison Road, St Ives Industrial Estate, St Ives 

Huntingdon, Cambs PE17 4LF 
Telephone: 01480 494262 Fax: 01480 495826 




SPECIALISING IN THE DESIGN 
& SHOPFITTING FOR THE 
PHARMACY TRADE. 

FOR YOUR INDIVIDUAL NEEDS 
TEL: 01392 491920 
TEL: 01392 49HH22 



the key to 

solve your pharmacy 




diofijjitiuuf. problems ^^r-^y — ^ 

• comprehensive service • part or full refits " N^n-*^ 

• competitive quotations • free advice 'budgets 

write/telephone: fredenck moore, 39 cooks meadow 
edlesborough, beds Iu6 2rp a 01525 222526 

name & address 



43? 



Manufacturers of Special . Pharmaceutical Products 

Bespoked Tailors of Pharmaceuticals offering 

A TRADITIONAL SPECIALS SERVICE 

for that "specials" patient cared for by that special 
professional 

Where confidence in quality and price is a must and where the 
minimum order value is ONE. 

Contact Karol Pazik, Director, on 01296 394142. 
Mandeville Medicines, The Specialists in Specials. 
For sterile, non-sterile and assembled specials, clinical trials 
supplies and a free help line 



STOCK FOR SALE 



5 x 60 MST lOOmg 50% off trade. 
500 x 60 SELEGILINE 5mg 42% off trade. 
60 x 28 ZESTRIL 5mg 48% off trade. 
130 x 28 ISOSORBIDE MONONITRATE 60SR 35% off trade. 
15 x 25 ZOVIRAX 400mg 40% off trade. 
1000 x 24 exp own brand films 35mm 80 pence each. 

Contact: Kasumba Chemist 
261 Chesterfield Road, Sheffield, S. Yorks. S8 0RT 
Tel: 0114 255 4361 



STOCK WANTED 



WANTED 

Old chemist shop fittings, drug runs, bow 

cabinets etc. 
Complete shop interiors purchased. We try 
hardest, travel furthest, pay more. 

Telephone 01327 349249 days. 
01327 341192 Eves. Fax: 01327 349397 



CHEMIST - WANTED - PHARMACY 

Surplus Coloured Glass Bottles and Jars Wanted. 
Black Glass Jars. Drug Jars - Blue or Green. 
Blue Castor Oils. Coloured Soda Syphons. 
"Admiralty" Square Blue Poisons. Spare Stoppers. 
Common Blue "Not to be taken" Poisons - All shapes. 
Mixed Assortments of Surplus Bottles as above. 
Contact: Eric Padfield, 
18 Mulberry Gardens, Sherborne, Dorset. 
Tel: 01935 816073 Fax: 01935 814181 



HEMEX SHOW PA 
LUCY OR DEBBI 

377222 



To? 



CHEMIST & DRUGGIST 19% 



101 




UTDeoDle 




Dental aid delivery to Bihac 



A pharmacist has been involved 
in a live-day trek across Europe 
to deliver essential dental sup- 
plies to Bihac in the north west of 
Bosnia. 

Stephen Beasley, a pharmacy 
manager at R A Hopkins in 
Luton, Bedfordshire, made the 
journey last month to deliver 
54,500 of dental supplies as part 
of the work of local charity 
Balkan Relief. Bihac, with a pop- 
ulation of 180,000, has not seen 
real dental care for over four 
years. 

Mr Beasley has been involved 
with fund-raising for the charity 
and organised a sponsored swim 
in April. Septodont UK donated 
2,000 local anaesthetic vials and 
sterile needles, and gave sub- 
stantial discounts on other prod- 
ucts. Luton dentist Donald 
Cousin helped arrange the dona- 
tion of other supplies. 

The delivery, which also in- 
cluded new drills and materials 



to make dentures and fillings, 
was made to Bihac hospital. "It 
should enable routine dentistry 
to be carried out for several 
months," says Mr Beasley. "Imag- 
ine having your tooth filled with 
a blunt drill and no anaesthetic." 



Food, clothing, bicycles and 
toys were also taken in the truck 
that was co-driven by Philip 
Waters, a director of the stock- 
taking company Take-Stock. The 
brewer, Bass, supplied funds to 
pay for the truck's fuel. 




Stephen Beasley (centre) meets Adem Yusufagic, a dentist at the Bihac 
hospital dental clinic, whose relatives are refugees in the Luton area. 
Mr Beasley delivered news from them to Mr Yusufagic and his mother 




usmess news 



There is another new face at 
Chemist & Druggist. 

The recent restructuring of the 
editorial team has seen Guy 
L'Aimable (above) appointed as 
business editor 

Guy, who has ten years of 
reporting experience, joins C&D 
from World Tobacco where he 
was assistant editor for four and a 
half years. His previous experi- 
ence includes four years spent 
with Reed Business Publishing. 



Feeling a little bit under the weather? 



The two main topics of interest to 
the British are their health and the 
weather. What was on television 
last night also ranks highly as a con- 
versation topic. 

Now the British public can have 
their fill of all three with the launch 
of the 24-hour cable television 
channel 'The Weather Network'. 

Not only will the station pro- 



vide updated weather reports 
round the clock, it is also going to 
feature health tips presented by 
pharmacist Sharon Buckle. 

Ms Buckle works as group pub- 
lic relations manager for Boots the 
Chemists, and was approached by 
the TV company to provide short, 
educational health promotion 
inserts for broadcasting. 




Stars in his eyes ... 

A face that may become more 
familiar to you on television is 
getting a second airing on this 
page. 

Ortis Deley recently hosted his 
own television programme, but 
he appeared on this page in Octo- 
ber 1994 when he was still a Sun- 
derland pharmacy student. 

Back then, he was taking part 
in 'Blind Date' on ITV. When he 
sang for presenter Cilia Black, his 
talent was spotted and he was 
signed up by an agent. 

His new show, 'Passport to Pas- 
sion', was shown two weeks ago 
in the Friday night post -pub slot 
on ITV. The pilot programme had 
Ortis and co-presenter Sarah 
Matravers setting out "to discover 
whether Copenhagen is really a 
place to find tare romance". 

"I was over the moon when I 
was asked to present 'Passport to 
Passion' - and I really enjoyed 
doing it," he says. 

Although he graduated, Ortis 
has yet to qualify as a pharmacist. 
It seems the bright lights hold 
more attraction and he is now 
poised to sign a record deal. 



CPP exam success 

The College of Pharmacy Prac- 
tice has announced that it has 
seven new full members. 

The candidates who have suc- 
cessfully completed the Col- 
lege's membership examination 
are Alison Archer, Barend 
Arrthon, Raymond Atkinson, 
Nickos Efthynriou, Elizabeth 
Hardman, Alisorr MacRobbie and 
Lesley Webster. 

The closing date for registra- 
tion to the College's Assessments 
D, E and F examinations is 
August 9. Reports for Assess- 
ments D and F should be submit- 
ted by August 23. 

Further details can be ob- 
tained from Michelle Chaplin at 
the College by telephoning 01203 
692400. 




The former president of the Royal Pharmaceutical Society has been 
presented with the College of Pharmacy Practice's Schering Award. 
The presentation was made at the College's award dinner last month in 
Stratford-upon-Avon. Pictured are (standing, from left) Professor 
Graham Calder, speaker Clive Jackson, Brian Riley, Norman Morrow, 
Schering Health Care managing director Mike Wallace and College 
chairman Dr David Anderson; (seated, from left) Mary Tompkins, Ann 
Lewis, Joan Greenleaf and Elizabeth Roddick 



All rights reserved. No part, of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including photocopying, recording or any information storage 
or retrieval system without the express prior written consent of the publisher. The contents of Chemist. & Druggist are subject to reproduction in information storage and retrieval systems. Miller 
Freeman Professional Ltd may pass suitable reader addresses to other relevant suppliers. If you do not wish to receive sales information from oi lier companies please write to Ben Martin at Miller 
Freeman Professional Ltd. Origination by London Scanning, 24a Shore Rd, London. Printed by St Ives (Gillingham) Ltd, Gillingham, Kent. Registered at the Post Office as a Newspaper 22/19/24S 



m. 



CHEMIST & DRUGGIST 20 JULY 1996 



: H E M E X ' 9 6 COLY M PIaT) 1 - 2 SEPTEMBER 19 



New look 
hemex... 
New home... 
id a New era 

emex '96 is a bigger better 
dw. Two floors of Olympia 
dedicated to pharmacy 
□ducts, to beauty and 
althcare, to current topics 
d to help you maximise 
ur business potential.. 
10 floors which will 
3vide you with: 

ie New NPA Village 

i arena where existing and 
tential members, may see and 
ar what their trade association 
Joing. A place where you can 
ve your say and to seek advice 
current issues. 

ie New International 
ivilion 

ijor international companies will 
showing you what is new and 
lat will be arriving on the domes- 
market in the near future. 

ie New Demonstration 
and 

new concept to provide all 
itors with an opportunity to see 
citing new products and services 
action and a chance for you to 
.t the best before you buy. 

;w Seminars and Workshops 

rpose built theatres will be the 
itform for a series of provoking 
d serious discussions which relate to 
jr business, your profits, and how to 
nerate new growth without com- 
3mise. What to do, how to do it, and 
w to monitor the results. Subjects on 
s draft programme include; 
iecurity 

Original Pack Dispensing 
Alternative Therapies 
)avid and Goliath... how to work in 
larmony in the face of competition 
rom the multiples 

Vill IT work 7 .. Computing and its 
ole in the pharmacy 



No hard drive 
to Chemex. . . 



Vhat's new 
nake profit 



and will what's new 




m 



but you could win 
a 2Gb hard drive at 
Chemex this year \ 

15m b EDO RAM,./-gnt^ peakers and Wind ows 95, 



keyboard, sound ca 



The New Visitors Voucher Book 

An exciting new concept. Every registered 
visitor to Chemex '96 will receive a voucher 
book bursting with special offers and 
promotions. So you know where the best 
deals and the best incentives are before 
you even enter the exhibition hall. 

Stunning New Promotions 

Early indications show that a number of 
companies are supporting the biggest 
and most spectacular prizes ever seen 
at Chemex... so if you wish to increase 
your chances of winning... register now. 

The New Trade Show 

Every floor will be bustling with activity 
and this year's exhibition bookings 
would indicate that the recession is 
dead. Hundreds of exhibitors all eager 
to keep you abreast of the latest devel- 
opments... and gossip! Special offers, 
exclusive to Chemex '96, will be the 
common theme. 

New Venue 

Olympia 2 welcomes Chemex '96 to its 
new improved facilities. Olympia 2 has 
all the advantages you would expect 
from an international exhibition 
centre, convenient to all mainline 
railway stations as well as having its 
own tube station. Olympia 2 also 
features parking for up to 2100 
cars, so you will be assured of 
easy and convenient access. 

New Registration 
Competition - win a 
Multimedia Pro 120 PC 

When you pre-register you will receive the 
opportunity to win, for your business, a state 
of the art Pentium 120 Multimedia PC com- 
plete with 16mb EDO RAM, 2 Gb hard drive, 
Eight speed CD ROM, IS" SVGA colour monitor, 
keyboard, sound card with speakers and 
Windows "95, to boot 1 Every pre-registered 
visitor will be entered inio our tree to enter 
draw The winner will be advised of their suc- 
cess at Chemex '96 In addition all visitors 
who pre-register will receive a compliment- 
ary free gift pack of TRU-ALO, with a retail 
value of £23 25 Your gift pack will include 
Soothing Gel, Moisturiser, Moisturiser with 
Vitamin E, Antiseptic Cream and Liniment. 



boot. 



WORTH OVER £1*00 



Sponsored by 

CHEMIST& 
DRUGGIST 



Supported t 



MEMEX '96 

he UK show for pharmacists/ 
pharmacy buyers. 



141 M;l l- r I : . •: i; 

Miller Freeman Exhibitions Ltd. 
Marlowe House, 109 Station Road 
Sidcup, Kent DA15 7ET 
Internet: www.mf-exhibitions.co UK 




For the treatment ^ 
of verrucas, warts, V<** 
corns and calluses 

■ Uniquely formulated, clinically proven treatment 

■ Dries to form a water-resistant, protective barrier 

■ Designed to inhibit spread of the verruca/wart infection 

■ No plasters necessary ■ Simple, once-daily application 







i 



A bullseye for Bazuka! 

Bazuka Gel has taken the verruca/wart 
market by storm, soaring to brand leadership 
within months of its launch. 

With its clinically proven prescription 
heritage Bazuka offers simple, effective 
treatment for verrucas, warts, corns and 
calluses. It dries to form a unique, water- 
resistant protective barrier designed to 
help inhibit the spread of the verruca/wart 
infection, without the need for plasters. 

And wtfith continued heavyweight national 
press, radio and TV support, Bazuka sales 
will go from strength to strength. Be sure 
to keep up with demand! 




lor the treatment of verrucas, warts, corns and calluses 
171 



salicylic acid, lactic acid 



FORMS A WATER-RESISTANT BARRIER - NO NEED FOR PLASTERS 

BAZUKA Trademark and Product Licence held by Diomed Developments Ltd , Hitchin, SG4 7QR, UK Distributed by DDD Ltd , 94 Rickmansworth Road. Wattord. Herts. WD1 7JJ. UK Active Ingredients: 
Salicylic Acid BP 12 0% w/w, Lactic Acid BP 4 0% w/w Also contains Camphor BP, Pyroxylin BP, Ethanol (96%) BP, Ethyl Acetate Indications: For the treatment ot verrucas, warts, corns and calluses 
Directions lor adults, including the elderly, and children: Apply one or two drops to the lesion and allow to dry to form a small white patch The following day. carefully peel or pick oft the dried patch, 
and apply fiesh gel Once every week, before applying Iresh gel, gently rub the treated surface with the emery board provided Continue treatment until the condition has resolved This may take up to 12 
weeks for certain vemicas and warts Contra-indications: Not to be used on the face or anogenital regions, or by diabetics or individuals with poor blood circulation Not to be used on moles, birth marks, 
hairy warts, oi any othei lesion loi which the gel is not indicated Not to be used in cases of sensitivity to any ot the ingredients Precautions and Warnings: Keep away from the eyes, mucous membrane 
and from cuts and grazes Avoid spreading onto surrounding normal skin Do not use excessively Some mild, transient irritation may be expected, but in cases of more severe irritation, treatment should be 
discontinued Avoid inhaling vapour, and keep cap firmly closed when not in use Avoid contact with clothing, fabrics, plastics and other mat erials as it may cause damag e Keep all medicines out of the reach 
ill i hildren HIGHLY FLAMMABLE Keep away from flames Store at room temperature (not exceeding 25°C), with the cap replaced tightly jFOR EXTERNAL USE ONLY [ Legal Category: [T] (PL 0173/0161) 
Packs: 5g, RSP E4 35 (£3 70 exc VAT) 5/95